,drug_name,section_name,gpt_output
0,IMPAVIDO,adverse reactions,"nausea, vomiting, diarrhea, headache, decreased appetite, dizziness, abdominal pain, pruritus, somnolence, elevated transaminases, elevated creatinine, death, Stevens-Johnson syndrome, melena, thrombocytopenia, arthritis, skin rash, CTCAE Grade 4 diarrhea, CTCAE Grade 4 hyperbilirubinemia, asthenia, motion sickness, malaise, pyrexia, lymphangitis, agranulocytosis, generalized edema, peripheral edema, jaundice, seizure, scrotal pain, decreased ejaculate volume, absent ejaculation, epistaxis"
1,IMPAVIDO,boxed warnings,"embryo-fetal toxicity, fetal harm, fetal death, teratogenicity, death"
2,IMPAVIDO,warnings and precautions,"Embryo-Fetal Toxicity, Reproductive effects, Renal Effects, Hepatic Effects, Gastrointestinal Effects, Thrombocytopenia, Absorption of Oral Contraceptives, Stevens-Johnson syndrome, fetal harm, teratogenicity, death, impaired fertility, testicular atrophy, reversible follicular atresia, diestrus, reduced viable sperm counts, scrotal pain, decreased or absent ejaculation, Elevations of serum creatinine, Elevations in liver transaminases, ALT, AST, bilirubin, vomiting, diarrhea, volume depletion"
3,LIVALO,adverse reactions,"rhabdomyolysis, myoglobinuria, acute renal failure, myopathy, myositis, liver enzyme abnormalities, myalgia, back pain, diarrhea, constipation, pain in extremity, arthralgia, headache, influenza, nasopharyngitis, elevated creatine phosphokinase, transaminases, alkaline phosphatase, bilirubin, glucose, hypersensitivity reactions, rash, pruritus, urticaria, abdominal discomfort, abdominal pain, dyspepsia, nausea, asthenia, fatigue, malaise, hepatitis, jaundice, hepatic failure, dizziness, hypoesthesia, insomnia, depression, interstitial lung disease, erectile dysfunction, muscle spasms, cognitive impairment, memory loss, forgetfulness, amnesia, memory impairment, confusion, immune-mediated necrotizing myopathy, death"
4,LIVALO,warnings and precautions,"myopathy, rhabdomyolysis, acute renal failure, myoglobinuria, liver enzyme abnormalities, persistent elevations in hepatic transaminases, immune-mediated necrotizing myopathy (IMNM), elevated creatine kinase (CK) levels, muscle pain, tenderness, weakness, malaise, fever, serum transaminases increase (aspartate aminotransferase [AST]/serum glutamic-oxaloacetic transaminase, alanine aminotransferase [ALT]/serum glutamic-pyruvic transaminase), hepatic failure, fatal hepatic failure, non-fatal hepatic failure, hyperbilirubinemia, jaundice, increases in HbA1c, fasting serum glucose levels, death"
5,XENAZINE,adverse reactions,"Depression, suicidality, akathisia, restlessness, agitation, parkinsonism, dysphagia, sedation, somnolence, fatigue, insomnia, anxiety, nausea, irritability, decreased appetite, obsessive reaction, balance difficulty, bradykinesia, dizziness, dysarthria, unsteady gait, headache, vomiting, fall, laceration (head), ecchymosis, upper respiratory tract infection, shortness of breath, bronchitis, dysuria, diarrhea, tremor, confusion, worsening aggression, pneumonia, hyperhidrosis, skin rash"
6,XENAZINE,boxed warnings,"depression, suicidal thoughts, suicidality, worsening of depression, unusual changes in behavior, prior suicide attempts, prior suicide ideation"
7,XENAZINE,warnings and precautions,"worsening mood, cognition, rigidity, functional capacity, Neuroleptic Malignant Syndrome (NMS), restlessness, agitation, akathisia, parkinsonism, Dysphagia, aspiration pneumonia, Sedation/Somnolence, QTc prolongation, depression, cognitive decline, disability, suicidality, suicide, suicidal ideation, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure changes, tachycardia, diaphoresis, cardiac dysrhythmia, elevated creatinine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, bradykinesia, hypertonia, esophageal dysmotility, torsade de pointes-type ventricular tachycardia, postural dizziness, syncope, orthostatic hypotension, Hyperprolactinemia, amenorrhea, galactorrhea, gynecomastia, impotence, osteoporosis, Tardive Dyskinesia (TD)"
8,LINZESS,adverse reactions,"diarrhea, abdominal pain, flatulence, abdominal distension, viral gastroenteritis, headache, fecal incontinence, dehydration, gastroesophageal reflux disease, vomiting, fatigue, upper respiratory tract infection, sinusitis, dyspepsia, rectal hemorrhage, hematochezia, melena, allergic reactions, urticaria, hives"
9,LINZESS,boxed warnings,"deaths, dehydration"
10,LINZESS,warnings and precautions,"severe diarrhea, mortality due to dehydration, death"
11,OPSUMIT,adverse reactions,"Embryo-fetal toxicity, Hepatotoxicity, Decrease in Hemoglobin, Anemia, Nasopharyngitis, Pharyngitis, Bronchitis, Headache, Influenza, Urinary tract infection, Hypersensitivity reactions, Angioedema, Pruritus, Rash, Nasal congestion"
12,OPSUMIT,boxed warnings,embryo-fetal toxicity
13,OPSUMIT,warnings and precautions,"hepatotoxicity, liver failure, decreases in hemoglobin, pulmonary edema, decreases in sperm count"
14,ASCLERA,adverse reactions,"Injection site hematoma, Injection site irritation, Injection site discoloration, Injection site pain, Injection site pruritus, Injection site warmth, Neovascularisation, Injection site thrombosis, Anaphylactic shock, Angioedema, Urticaria generalized, Asthma, Cerebrovascular accident, Migraine, Paresthesia (local), Loss of consciousness, Confusional state, Dizziness, Cardiac arrest, Palpitations, Deep vein thrombosis, Pulmonary embolism, Syncope vasovagal, Circulatory collapse, Vasculitis, Dyspnea, Skin hyperpigmentation, Dermatitis allergic, Hypertrichosis (in the area of sclerotherapy), Injection site necrosis, Pyrexia, Hot flush, Nerve injury, death"
15,ASCLERA,warnings and precautions,"anaphylaxis, severe allergic reactions, death, tissue necrosis, extravasation, severe necrosis, ischemia, gangrene, pain"
16,KYNAMRO,adverse reactions,"hepatotoxicity, injection site reactions, flu-like symptoms, nausea, headache, elevations in serum transaminases, ALT increased, alanine aminotransferase increased, aspartate aminotransferase increased, liver function test abnormal, angina pectoris, palpitations, vomiting, abdominal pain, fatigue, influenza like illness, pyrexia, chills, edema peripheral, hepatic steatosis, pain in extremity, musculoskeletal pain, insomnia, hypertension, hypersensitivity reaction, angioedema, glomerular nephritis, thrombocytopenic purpura, death"
17,KYNAMRO,boxed warnings,"hepatotoxicity, elevations in transaminases, elevation in alanine aminotransferase (ALT) >= 3x upper limit of normal (ULN), hepatic fat increase, hepatic steatosis, steatohepatitis, cirrhosis, clinically significant liver toxicity"
18,KYNAMRO,warnings and precautions,"injection site reactions, erythema, pain, tenderness, pruritus, local swelling, flu-like symptoms, influenza-like illness, pyrexia, chills, myalgia, arthralgia, malaise, fatigue, hepatotoxicity, elevations in transaminases, hepatic steatosis, steatohepatitis, cirrhosis, nausea, vomiting, abdominal pain, fever, jaundice, lethargy, increases in bilirubin"
19,XARELTO,adverse reactions,"increased risk of stroke, bleeding risk, spinal/epidural hematoma, bleeding, hemorrhage, major bleeding, bleeding into a critical organ, fatal bleeding, gastrointestinal bleeding, non-fatal critical organ bleeding, non-fatal non-critical organ bleeding, clinically relevant non-major bleeding, any bleeding, menorrhagia, abdominal pain upper, dyspepsia, toothache, fatigue, sinusitis, urinary tract infection, back pain, osteoarthritis, oropharyngeal pain, wound secretion, pain in extremity, muscle spasm, syncope, pruritus, blister, pulmonary hemorrhage, agranulocytosis, thrombocytopenia, retroperitoneal hemorrhage, jaundice, cholestasis, hepatitis, hepatocellular injury, hypersensitivity, anaphylactic reaction, anaphylactic shock, angioedema, cerebral hemorrhage, subdural hematoma, epidural hematoma, hemiparesis, Stevens-Johnson syndrome, death"
20,XARELTO,boxed warnings,"thrombotic events, spinal/epidural hematoma, long-term or permanent paralysis, neurological impairment"
21,XARELTO,warnings and precautions,"bleeding, fatal bleeding, death, obstetric hemorrhage, thrombotic events, stroke, pathological hemorrhage, epidural or spinal hematoma, paralysis, acute renal failure, coagulopathy, pregnancy-related hemorrhage"
22,CAPRELSA,adverse reactions,"QT Prolongation, Torsades de Pointes, Skin Reactions, Stevens-Johnson Syndrome, Interstitial Lung Disease, Ischemic Cerebrovascular Events, Hemorrhage, Heart Failure, Diarrhea, Hypothyroidism, Hypertension, Reversible Posterior Leukoencephalopathy Syndrome, Embryofetal Toxicity, colitis, rash, acneiform dermatitis, nausea, headache, upper respiratory tract infections, decreased appetite, abdominal pain, asthenia, fatigue, pyrexia, elevated creatinine, vomiting, dyspepsia, dry mouth, photosensitivity reaction, pruritus, nail abnormalities, alopecia, hypertensive crisis, accelerated hypertension, dysgeusia, hypocalcemia, ECG QT Prolonged, corneal abnormalities, blurred vision, proteinuria, depression, muscle spasms, pancreatitis, intestinal perforation, bleeding events, hypocalcemia, ALT increased, hypoglycemia, creatinine increased, hypomagnesemia, neutropenia, thrombocytopenia."
23,CAPRELSA,boxed warnings,"QT prolongation, Torsades de Pointes, sudden death, hypocalcemia, hypokalemia, hypomagnesemia, long QT syndrome, death"
24,CAPRELSA,warnings and precautions,"Prolonged QT Interval, Torsades de pointes, sudden death, Severe skin reactions, Stevens-Johnson syndrome, death, Interstitial lung disease (ILD), fatalities, Ischemic cerebrovascular events, hemorrhage, heart failure, diarrhea, hypertension, reversible posterior leukoencephalopathy syndrome, Embryofetal toxicity, photosensitivity reactions, hypothyroidism, hypertensive crisis, Reversible Posterior Leukoencephalopathy Syndrome (RPLS)"
25,KADCYLA,adverse reactions,"Hepatotoxicity, Left Ventricular Dysfunction, Embryo-Fetal Toxicity, Pulmonary Toxicity, Infusion-Related Reactions, Hypersensitivity Reactions, Hemorrhage, Thrombocytopenia, Neurotoxicity, fatigue, nausea, musculoskeletal pain, headache, increased transaminases, constipation, epistaxis, Neutropenia, Anemia, Lacrimation increased, Dry eye, Vision blurred, Conjunctivitis, Dyspepsia, Stomatitis, Dry Mouth, Abdominal pain, Vomiting, Diarrhea, Peripheral edema, Chills, Pyrexia, Asthenia, Nodular regenerative hyperplasia, Portal hypertension, Drug hypersensitivity, Infusion-related reaction, Urinary tract infection, Blood alkaline phosphatase increased, Hypokalemia, Myalgia, Arthralgia, Dysgeusia, Dizziness, Peripheral neuropathy, Insomnia, Pneumonitis, Dyspnea, Cough, Pruritus, Rash, Hypertension, Increased bilirubin, Increased AST, Increased ALT, Decreased platelet count, Decreased hemoglobin, Decreased neutrophils, Decreased potassium, Hepatic failure, death"
26,KADCYLA,boxed warnings,"hepatotoxicity, liver failure, death, cardiac toxicity, reductions in left ventricular ejection fraction (LVEF), embryo-fetal death, birth defects"
27,KADCYLA,warnings and precautions,"pulmonary toxicity, interstitial lung disease, pneumonitis, death, infusion-related reactions, hypersensitivity reactions, life-threatening infusion-related reaction, hemorrhage, fatal hemorrhage, thrombocytopenia, neurotoxicity, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, hepatotoxicity, severe drug-induced liver injury, hepatic encephalopathy, death, nodular regenerative hyperplasia, non-cirrhotic portal hypertension, left ventricular dysfunction, embryo-fetal toxicity, oligohydramnios, pulmonary hypoplasia, skeletal abnormalities, neonatal death, acute respiratory distress syndrome, dyspnea, cough, fatigue, pulmonary infiltrates, flushing, chills, pyrexia, hypotension, wheezing, bronchospasm, tachycardia, allergic/anaphylactic-like reaction, central nervous system hemorrhage, respiratory hemorrhage, gastrointestinal hemorrhage, extravasation, erythema, tenderness, skin irritation, pain, swelling at the infusion site"
28,RELISTOR,adverse reactions,"Gastrointestinal perforation, Severe or persistent diarrhea, Opioid withdrawal, Abdominal pain, Nausea, Diarrhea, Hyperhidrosis, Hot flush, Tremor, Chills, Flatulence, Dizziness, Vomiting, Feeling of body temperature change, Piloerection, Myocardial infarction (death), Stroke (death), Cardiac arrest (death), Sudden death, Cramping, Diaphoresis, Flushing, Malaise, Pain"
29,RELISTOR,warnings and precautions,"Gastrointestinal perforation, severe or persistent diarrhea, opioid withdrawal, hyperhidrosis, chills, abdominal pain, anxiety, yawning"
30,JUXTAPID,adverse reactions,"hepatotoxicity, reduced absorption of fat-soluble vitamins, serum fatty acids, gastrointestinal adverse reactions, diarrhea, nausea, vomiting, dyspepsia, abdominal pain, treatment discontinuations, gastroenteritis, weight loss, headache, difficulty controlling INR on warfarin, abdominal discomfort, abdominal distension, constipation, flatulence, increased ALT, chest pain, influenza, nasopharyngitis, fatigue, gastroesophageal reflux disease, defecation urgency, rectal tenesmus, decreased weight, fever, back pain, dizziness, pharyngolaryngeal pain, nasal congestion, angina pectoris, palpitations, severe intensity adverse reactions, transaminase elevations, hepatic steatosis"
31,JUXTAPID,boxed warnings,"hepatotoxicity, elevations in transaminases, elevation in alanine aminotransferase (ALT), elevation in aspartate aminotransferase (AST), hepatic fat increase, hepatic steatosis, progressive liver disease, steatohepatitis, cirrhosis"
32,JUXTAPID,warnings and precautions,"Embryo-Fetal Toxicity, Gastrointestinal adverse reactions, Elevation of Transaminases, Hepatic Steatosis, Reduced Absorption of Fat-Soluble Vitamins and Serum Fatty Acids, Risk of Myopathy, Supratherapeutic or Subtherapeutic Anticoagulation with Warfarin, Risk of Malabsorption with Rare Hereditary Disorders of Galactose Intolerance"
33,SAVELLA,adverse reactions,"nausea, headache, constipation, dizziness, insomnia, hot flush, hyperhidrosis, vomiting, palpitations, heart rate increased, dry mouth, hypertension, tachycardia, vision blurred, abdominal pain, chest pain, chills, chest discomfort, upper respiratory tract infection, blood pressure increased, decreased appetite, migraine, paresthesia, tremor, hypoesthesia, tension headache, anxiety, dyspnea, rash, pruritus, flushing, weight loss, weight gain, dysuria, ejaculation disorder, erectile dysfunction, ejaculation failure, libido decreased, prostatitis, scrotal pain, testicular pain, testicular swelling, urinary hesitation, urinary retention, urethral pain, urine flow decreased, diarrhea, dyspepsia, gastroesophageal reflux disease, flatulence, abdominal distension, fatigue, peripheral edema, irritability, pyrexia, urinary tract infection, cystitis, contusion, fall, hypercholesterolemia, somnolence, dysgeusia, depression, stress, night sweats, leukopenia, neutropenia, thrombocytopenia, supraventricular tachycardia, accommodation disorder, hyperprolactinemia, hepatitis, anorexia, hyponatremia, rhabdomyolysis, convulsions, loss of consciousness, Parkinsonism, aggression, anger, delirium, hallucination, homicidal ideation, acute renal failure, galactorrhea, erythema multiforme, Stevens Johnson syndrome, hypertensive crisis"
34,SAVELLA,boxed warnings,"suicidal thinking, suicidality, behavior changes, clinical worsening, unusual changes in behavior"
35,SAVELLA,warnings and precautions,"suicidality, suicide risk, worsening of depressive symptoms, emergence of suicidal ideation and behavior, unusual changes in behavior, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, Serotonin Syndrome, elevated blood pressure, heart rate elevations, hypertension, Seizures, Hepatotoxicity, mild elevations of ALT and AST, fulminant hepatitis, jaundice, liver dysfunction, Withdrawal symptoms, physical dependence, dysphoric mood, dizziness, sensory disturbances (e.g., paresthesias such as electric shock sensations), confusion, headache, lethargy, emotional lability, hypomania, tinnitus, seizures, Hyponatremia, headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, seizure, coma, respiratory arrest, death, Abnormal Bleeding, gastrointestinal bleeding, ecchymoses, hematomas, epistaxis, petechiae, hemorrhages, Activation of Mania, hypomania, Dysuria, urinary retention, testicular pain, ejaculation disorders, Angle Closure Glaucoma, elevated transaminases, chronic liver disease"
36,SAMSCA,adverse reactions,"thirst, dry mouth, asthenia, constipation, pollakiuria, polyuria, hyperglycemia, death, pyrexia, anorexia, nausea, gastrointestinal bleeding, disseminated intravascular coagulation, intracardiac thrombus, ventricular fibrillation, prothrombin time prolonged, ischemic colitis, diabetic ketoacidosis, rhabdomyolysis, cerebrovascular accident, urethral hemorrhage, vaginal hemorrhage, pulmonary embolism, respiratory failure, deep vein thrombosis, osmotic demyelination syndrome, hypernatremia, hypersensitivity reactions, anaphylactic shock, rash generalized"
37,SAMSCA,boxed warnings,"osmotic demyelination, dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma, death"
38,SAMSCA,warnings and precautions,"Liver injury, Dehydration, Hypovolemia, Osmotic demyelination syndrome, Dysarthria, Mutism, Dysphagia, Lethargy, Affective changes, Spastic quadriparesis, Seizures, Coma, Death, Hyperkalemia"
39,JETREA,adverse reactions,"Decreased Vision, Intravitreal Injection Procedure Associated Effects, Potential for Lens Subluxation, Retinal Breaks, vitreous floaters, conjunctival hemorrhage, eye pain, photopsia, blurred vision, macular hole, reduced visual acuity, visual impairment, retinal edema, macular edema, increased intraocular pressure, anterior chamber cell, photophobia, vitreous detachment, ocular discomfort, iritis, cataract, dry eye, metamorphopsia, conjunctival hyperemia, retinal degeneration, dyschromatopsia"
40,JETREA,warnings and precautions,"decreased vision, intraocular inflammation, intraocular hemorrhage, increased intraocular pressure, lens subluxation, retinal detachment, retinal tear, dyschromatopsia, death"
41,OPDIVO,adverse reactions,"Immune-Mediated Pneumonitis, Immune-Mediated Colitis, Immune-Mediated Hepatitis, Immune-Mediated Nephritis, Renal Dysfunction, Immune-Mediated Hypothyroidism, Immune-Mediated Hyperthyroidism, Other Immune-Mediated Adverse Reactions, Rash, Fatigue, Dyspnea, Musculoskeletal Pain, Decreased Appetite, Cough, Nausea, Constipation, Abdominal Pain, Hyponatremia, Increased Aspartate Aminotransferase, Increased Lipase, Pruritus, Upper Respiratory Tract Infection, Peripheral Edema, Ventricular Arrhythmia, Iridocyclitis, Infusion-Related Reactions, Increased Amylase, Dizziness, Peripheral and Sensory Neuropathy, Exfoliative Dermatitis, Erythema Multiforme, Vitiligo, Psoriasis, Increased Alkaline Phosphatase, Increased ALT, Hyperkalemia, Asthenia, Edema, Pyrexia, Chest Pain, Pain, Arthralgia, Vomiting, Diarrhea, Decreased Weight, Pneumonia, Stomatitis, Peripheral Neuropathy, Bronchitis, Hyponatremia, Increased Creatinine, Hypercalcemia, Hypokalemia, Hypomagnesemia, Hypocalcemia, Hyperkalemia, Increased AST, Increased Alkaline Phosphatase, Increased ALT, Lymphopenia, Anemia, Thrombocytopenia"
42,OPDIVO,warnings and precautions,"immune-mediated pneumonitis, interstitial lung disease, death, immune-mediated colitis, diarrhea, immune-mediated hepatitis, liver test abnormalities, AST elevation, alkaline phosphatase elevation, ALT elevation, total bilirubin elevation, immune-mediated nephritis, renal dysfunction, elevated creatinine, immune-mediated hypothyroidism, hypothyroidism, hyperthyroidism, adrenal insufficiency, uveitis, pancreatitis, facial nerve paresis, abducens nerve paresis, demyelination, autoimmune neuropathy, motor dysfunction, vasculitis, hypophysitis, diabetic ketoacidosis, hypopituitarism, Guillain-Barre syndrome, myasthenic syndrome, embryofetal toxicity"
43,VICTOZA,adverse reactions,"Risk of Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Renal Impairment, Hypersensitivity Reactions, headache, nausea, diarrhea, anti-liraglutide antibody formation, Immunogenicity-related events, urticaria, gastrointestinal adverse reactions, vomiting, dyspepsia, constipation, injection site reactions, papillary thyroid carcinoma, dehydration, increased serum creatinine, acute renal failure, worsening of chronic renal failure, angioedema, anaphylactic reactions, rash, pruritus, acute pancreatitis, hemorrhagic pancreatitis, necrotizing pancreatitis, death"
44,VICTOZA,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
45,VICTOZA,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, fatal pancreatitis, non-fatal hemorrhagic pancreatitis, necrotizing pancreatitis, Serious Hypoglycemia, Renal Impairment, acute renal failure, worsening of chronic renal failure, Hypersensitivity, anaphylactic reactions, angioedema, death"
46,EFFIENT,adverse reactions,"Bleeding, life-threatening bleeding, fatal bleeding, death, thrombotic thrombocytopenic purpura, symptomatic intracranial hemorrhage, hemorrhagic events (epistaxis, gastrointestinal hemorrhage, hemoptysis, subcutaneous hematoma, post-procedural hemorrhage, retroperitoneal hemorrhage, pericardial effusion/hemorrhage/tamponade), severe thrombocytopenia, anemia, abnormal hepatic function, allergic reactions, angioedema, thrombocytopenia, thrombotic thrombocytopenic purpura (TTP), hypersensitivity reactions including anaphylaxis"
47,EFFIENT,boxed warnings,"significant bleeding, fatal bleeding, death, active pathological bleeding, intracranial bleeding, hypotensive"
48,EFFIENT,warnings and precautions,"CABG-related bleeding, stent thrombosis, myocardial infarction (MI), death, thrombotic thrombocytopenic purpura (TTP), hypersensitivity, angioedema, bleeding, TIMI Major bleeding, TIMI Minor bleeding, hypotensive, active bleeding, TIA, stroke, fatal bleeding, gastrointestinal (GI) bleeding, active peptic ulcer disease, severe hepatic impairment, moderate to severe renal impairment."
49,ENTYVIO,adverse reactions,"Infusion-Related Reactions, Hypersensitivity Reactions, anaphylaxis, dyspnea, bronchospasm, urticaria, flushing, rash, increased blood pressure, heart rate, nausea, headache, pruritus, dizziness, fatigue, infusion-related reaction, pyrexia, vomiting, Infections, nasopharyngitis, upper respiratory tract infection, sinusitis, urinary tract infection, anal abscess, sepsis, tuberculosis, salmonella sepsis, Listeria meningitis, giardiasis, cytomegaloviral colitis, Liver Injury, hepatitis, elevated transaminases, elevated bilirubin, malaise, Malignancies, colon cancer, transitional cell carcinoma, breast cancer, carcinoid tumor, squamous cell carcinoma, B-cell lymphoma, malignant hepatic neoplasm, malignant lung neoplasm, malignant melanoma, primary neuroendocrine carcinoma, renal cancer, death"
50,ENTYVIO,warnings and precautions,"Hypersensitivity Reactions, anaphylaxis, serious allergic reactions, Infections, severe infections, Progressive Multifocal Leukoencephalopathy (PML), death, Infusion-Related Reactions, dyspnea, bronchospasm, urticaria, flushing, rash, increased blood pressure, increased heart rate, nasopharyngitis, upper respiratory tract infection, anal abscess, sepsis, tuberculosis, salmonella sepsis, Listeria meningitis, giardiasis, cytomegaloviral colitis, neurological signs or symptoms, progressive weakness, clumsiness of limbs, disturbance of vision, changes in thinking, memory, orientation leading to confusion, personality changes, severe disability, Liver Injury, elevations of transaminase, elevated bilirubin, severe liver injury, jaundice."
51,ADEMPAS,adverse reactions,"Embryo-Fetal Toxicity, Hypotension, Bleeding, Headache, Dyspepsia, Gastritis, Dizziness, Nausea, Diarrhea, Vomiting, Anemia, Gastroesophageal Reflux Disease, Constipation, Palpitations, Nasal Congestion, Epistaxis, Dysphagia, Abdominal Distension, Peripheral Edema"
52,ADEMPAS,boxed warnings,embryo-fetal toxicity
53,ADEMPAS,warnings and precautions,"symptomatic hypotension, bleeding, pulmonary edema, fetal harm, death"
54,MOVANTIK,adverse reactions,"Gastrointestinal perforation, Opioid withdrawal, Abdominal pain, Diarrhea, Nausea, Flatulence, Vomiting, Headache, Hyperhidrosis, Chills, Anxiety, Irritability, Yawning"
55,MOVANTIK,warnings and precautions,"Gastrointestinal perforation, severe abdominal pain, persistent abdominal pain, worsening abdominal pain, opioid withdrawal, hyperhidrosis, chills, diarrhea, anxiety, irritability, yawning"
56,STIVARGA,adverse reactions,"hepatotoxicity, hemorrhage, death, dermatological toxicity, hypertension, cardiac ischemia, infarction, reversible posterior leukoencephalopathy syndrome (RPLS), gastrointestinal perforation, fistula, asthenia/fatigue, hand-foot skin reaction (HFSR), diarrhea, decreased appetite/food intake, mucositis, dysphonia, infection, pain (not otherwise specified), decreased weight, gastrointestinal and abdominal pain, rash, fever, nausea, anemia, thrombocytopenia, neutropenia, lymphopenia, hypocalcemia, hypokalemia, hyponatremia, hypophosphatemia, hyperbilirubinemia, increased AST, increased ALT, proteinuria, increased INR, increased lipase, increased amylase, alopecia, hypothyroidism, headache, musculoskeletal stiffness, hypersensitivity reaction"
57,STIVARGA,boxed warnings,"hepatotoxicity, severe hepatotoxicity, fatal hepatotoxicity, elevated liver function tests, hepatocellular necrosis, death"
58,STIVARGA,warnings and precautions,"Hemorrhage, Dermatological toxicity, Hypertension, Cardiac ischemia and infarction, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), Gastrointestinal perforation or fistulae, Wound healing complications, Embryofetal toxicity, Hepatotoxicity, Hepatocellular necrosis, Fatal hepatic failure, Hand-foot skin reaction (HFSR), Palmar-plantar erythrodysesthesia (PPE), Severe rash, Erythema multiforme, Stevens Johnson Syndrome, Toxic epidermal necrolysis, Hypertensive crisis, death"
59,ANORO,adverse reactions,"asthma-related death, paradoxical bronchospasm, cardiovascular effects, worsening of narrow-angle glaucoma, worsening of urinary retention, pharyngitis, sinusitis, lower respiratory tract infection, constipation, diarrhea, pain in extremity, muscle spasms, neck pain, chest pain, productive cough, dry mouth, dyspepsia, abdominal pain, gastroesophageal reflux disease, vomiting, musculoskeletal chest pain, chest discomfort, asthenia, atrial fibrillation, ventricular extrasystoles, supraventricular extrasystoles, myocardial infarction, pruritus, rash, conjunctivitis, headache, back pain, cough, urinary tract infection, arthralgia, nausea, vertigo, pleuritic pain, viral respiratory tract infection, toothache, diabetes mellitus, death"
60,ANORO,boxed warnings,asthma-related death
61,ANORO,warnings and precautions,"asthma-related death, paradoxical bronchospasm, cardiovascular effects, hypersensitivity reactions, anaphylactic reactions, increases in pulse rate, systolic or diastolic blood pressure, electrocardiographic changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, convulsive disorders, thyrotoxicosis, diabetes mellitus aggravation, ketoacidosis, worsening of narrow-angle glaucoma, worsening of urinary retention, hypokalemia, hyperglycemia, death"
62,VIMPAT,adverse reactions,"Suicidal Behavior and Ideation, Dizziness, Ataxia, Cardiac Rhythm and Conduction Abnormalities, Syncope, Multiorgan Hypersensitivity Reactions, Diplopia, Headache, Nausea, Insomnia, Vomiting, Vertigo, Blurred Vision, Diarrhea, Fatigue, Gait Disturbance, Asthenia, Contusion, Skin Laceration, Somnolence, Tremor, Nystagmus, Balance Disorder, Memory Impairment, Depression, Pruritus, Neutropenia, Anemia, Palpitations, Tinnitus, Constipation, Dyspepsia, Dry Mouth, Oral Hypoaesthesia, Irritability, Pyrexia, Feeling Drunk, Fall, Muscle Spasms, Paresthesia, Cognitive Disorder, Hypoaesthesia, Dysarthria, Disturbance in Attention, Cerebellar Syndrome, Confusional State, Mood Altered, Depressed Mood, Injection Site Pain, Injection Site Discomfort, Injection Site Irritation, Injection Site Erythema, Profound Bradycardia, Oral Paresthesia, Chest Pain, Abnormal Coordination, Hyperhidrosis, Agranulocytosis, Aggression, Agitation, Hallucination, Psychotic Disorder, Angioedema, Rash, Urticaria, Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, Liver Function Test Abnormalities, Hepatitis, Nephritis, Death (due to the mention of fatal events like Stevens-Johnson syndrome and toxic epidermal necrolysis which can be fatal)."
63,VIMPAT,warnings and precautions,"suicidal behavior and ideation, dizziness, ataxia, cardiac rhythm and conduction abnormalities, syncope, increased seizure frequency, multiorgan hypersensitivity reactions, symptomatic hepatitis, nephritis, rash, elevated liver enzymes, myocarditis, atrial fibrillation, atrial flutter, first-degree atrioventricular block, second-degree AV block, complete AV block, profound bradycardia, death"
64,BANZEL,adverse reactions,"Suicidal Behavior and Ideation, Central Nervous System Reactions, QT Shortening, Multi-Organ Hypersensitivity/Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Leukopenia, headache, dizziness, fatigue, somnolence, nausea, vomiting, influenza, nasopharyngitis, decreased appetite, rash, ataxia, diplopia, bronchitis, sinusitis, psychomotor hyperactivity, upper abdominal pain, aggression, ear infection, disturbance in attention, pruritis, tremor, nystagmus, blurred vision, anxiety, constipation, dyspepsia, back pain, gait disturbance, vertigo, convulsion, anemia, lymphadenopathy, neutropenia, iron deficiency anemia, thrombocytopenia, bundle branch block right, atrioventricular block first degree, pollakiuria, urinary incontinence, dysuria, hematuria, nephrolithiasis, polyuria, enuresis, nocturia, incontinence, Stevens-Johnson syndrome"
65,BANZEL,warnings and precautions,"new or worsening depression, suicidal thoughts/behavior, unusual changes in mood or behavior, central nervous system reactions, multi-organ hypersensitivity reaction, seizure exacerbation, status epilepticus, somnolence, fatigue, coordination abnormalities, dizziness, gait disturbances, ataxia, QT shortening, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), leukopenia, death"
66,XELJANZ,adverse reactions,"upper respiratory tract infections, headache, diarrhea, nasopharyngitis, serious infections, pneumonia, cellulitis, herpes zoster, urinary tract infections, tuberculosis, opportunistic infections, malignancies excluding NMSC, lymphoma, lung cancer, breast cancer, gastric cancer, colorectal cancer, renal cell cancer, prostate cancer, malignant melanoma, lymphopenia, neutropenia, liver enzyme elevations, drug-induced liver injury, lipid elevations, serum creatinine elevations, anemia, diverticulitis, dehydration, insomnia, paresthesia, dyspnea, cough, sinus congestion, abdominal pain, dyspepsia, vomiting, gastritis, nausea, hepatic steatosis, rash, erythema, pruritus, musculoskeletal pain, arthralgia, tendonitis, joint swelling, non-melanoma skin cancers, pyrexia, fatigue, peripheral edema"
67,XELJANZ,boxed warnings,"serious infections, hospitalization, death, tuberculosis, bacterial infections, invasive fungal infections, viral infections, other opportunistic infections, lymphoma, malignancies, Epstein Barr Virus-associated post-transplant lymphoproliferative disorder"
68,XELJANZ,warnings and precautions,"serious infections, bacterial infections, mycobacterial infections, invasive fungal infections, viral infections, opportunistic infections, pneumonia, cellulitis, herpes zoster, urinary tract infection, diverticulitis, tuberculosis, cryptococcosis, esophageal candidiasis, pneumocystosis, multidermatomal herpes zoster, cytomegalovirus, BK virus, sepsis, malignancy, lymphoproliferative disorders, solid cancers, lymphoma, Epstein Barr Virus-associated post-transplant lymphoproliferative disorder, non-melanoma skin cancer, gastrointestinal perforation, lymphocyte abnormalities, lymphocytosis, neutropenia, anemia, liver enzyme elevations, lipid elevations, death"
69,GATTEX,adverse reactions,"abdominal pain, injection site reactions, nausea, headaches, abdominal distension, upper respiratory tract infection, vomiting, fluid overload, flatulence, hypersensitivity, appetite disorders, sleep disturbances, cough, skin hemorrhage, gastrointestinal stoma complication, malignancy, colorectal polyps, gastrointestinal obstruction, gallbladder disease, biliary disease, pancreatic disease, congestive heart failure, cognition and attention disturbances, immunogenicity"
70,GATTEX,warnings and precautions,"neoplastic growth, acceleration of neoplastic growth, intestinal obstruction, biliary disease, pancreatic disease, fluid overload, congestive heart failure, colorectal polyps, small bowel neoplasia, cholecystitis, cholangitis, cholelithiasis, pancreatitis, altered mental status"
71,XOFIGO,adverse reactions,"Bone Marrow Suppression, nausea, diarrhea, vomiting, peripheral edema, anemia, lymphocytopenia, leukopenia, thrombocytopenia, neutropenia, pancytopenia, renal failure and impairment, dehydration, erythema, pain, edema at the injection site, secondary malignant neoplasms, osteosarcoma."
72,XOFIGO,warnings and precautions,"Bone Marrow Suppression, bone marrow failure, ongoing pancytopenia, death, blood transfusions, bone marrow suppression, vascular hemorrhage, myelosuppression, infection-related deaths, serious infections, febrile neutropenia, thrombocytopenia, neutropenia, pancytopenia, leukopenia, life-threatening complications"
73,SYNRIBO,adverse reactions,"myelosuppression, bleeding, hyperglycemia, thrombocytopenia, anemia, neutropenia, diarrhea, nausea, fatigue, asthenia, injection site reaction, pyrexia, infection, lymphopenia, pancytopenia, increased alanine aminotransferase, bone marrow failure, febrile neutropenia, constipation, abdominal pain, upper abdominal pain, vomiting, edema peripheral, anorexia, arthralgia, pain in extremity, back pain, myalgia, headache, insomnia, cough, epistaxis, alopecia, rash, leukocytosis, chills, dyspnea, death, hyperosmolar non-ketotic hyperglycemia, elevated transaminases, hemoglobin decreased, leukocytes decreased, neutrophils decreased, platelets decreased, alanine aminotransferase increased, bilirubin increased, creatinine increased, glucose increased, uric acid increased, glucose decreased, tachycardia, palpitations, acute coronary syndrome, angina pectoris, arrhythmia, bradycardia, ventricular extrasystoles, ear pain, ear hemorrhage, tinnitus, cataract, vision blurred, conjunctival hemorrhage, dry eye, lacrimation increased, conjunctivitis, diplopia, eye pain, eyelid edema, stomatitis, mouth ulceration, abdominal distension, dyspepsia, gastroesophageal reflux disease, gingival bleeding, aphthous stomatitis, dry mouth, hemorrhoids, gastritis, gastrointestinal hemorrhage, melena, mouth hemorrhage, oral pain, anal fissure, dysphagia, gingival pain, gingivitis, mucosal inflammation, pain, chest pain, hyperthermia, influenza-like illness, catheter site pain, general edema, malaise, hypersensitivity, contusion, transfusion reaction, decreased appetite, diabetes mellitus, gout, dehydration, bone pain, muscular weakness, muscle spasms, musculoskeletal chest pain, musculoskeletal pain, musculoskeletal stiffness, musculoskeletal discomfort, dizziness, cerebral hemorrhage, paresthesia, convulsion, hypoesthesia, lethargy, sciatica, burning sensation, dysgeusia, tremor, anxiety, depression, agitation, confusional state, mental status change, dysuria, pharyngolaryngeal pain, nasal congestion, dysphonia, productive cough, rales, rhinorrhea, hemoptysis, sinus congestion, erythema, pruritus, dry skin, petechiae, hyperhidrosis, night sweats, ecchymosis, purpura, skin lesion, skin ulcer, rash erythematous, rash papular, skin exfoliation, skin hyperpigmentation, hematoma, hypertension, hot flush, hypotension."
74,SYNRIBO,warnings and precautions,"myelosuppression, death, thrombocytopenia, neutropenia, anemia, bleeding, increased risk of hemorrhage, fatal cerebral hemorrhage, severe non-fatal gastrointestinal hemorrhage, hyperglycemia, glucose intolerance, hyperosmolar non-ketotic hyperglycemia, embryo-fetal toxicity, fetal harm, infections, fever"
75,ICLUSIG,adverse reactions,"Vascular Occlusion, Heart Failure, Hepatotoxicity, Hypertension, Pancreatitis, Neuropathy, Ocular Toxicity, Hemorrhage, Fluid Retention, Cardiac Arrhythmias, Myelosuppression, Arterial ischemia, Thrombocytopenia, Infections, Abdominal pain, Constipation, Nausea, Diarrhea, Vomiting, Oral mucositis, GI hemorrhage, Febrile neutropenia, Sepsis, Pneumonia, Urinary tract infection, Upper respiratory tract infection, Nasopharyngitis, Cellulitis, Headache, Peripheral neuropathy, Dizziness, Pleural effusion, Cough, Dyspnea, Rash and related conditions, Dry skin, Arthralgia, Myalgia, Pain in extremity, Back pain, Muscle spasms, Bone pain, Fatigue or asthenia, Pyrexia, Edema, peripheral, Pain, Chills, Decreased appetite, Weight decreased, Insomnia, Arterial ischemic event, Cardiovascular, Cerebrovascular, Peripheral vascular, CNS hemorrhage, Gastrointestinal hemorrhage, Cardiac failure, Effusions, Atrial fibrillation, Venous thromboembolism, Anemia, Lymphopenia, Leukopenia, ALT increased, AST increased, Alkaline phosphatase increased, Albumin decreased, Bilirubin increased, Lipase increased, Amylase increased, Glucose increased, Phosphorus decreased, Calcium decreased, Sodium decreased, Glucose decreased, Potassium decreased, Potassium increased, Sodium increased, Bicarbonate decreased, Creatinine increased, Calcium increased, Triglycerides increased"
76,ICLUSIG,boxed warnings,"vascular occlusion, arterial thrombosis, venous thrombosis, myocardial infarction, stroke, stenosis of large arterial vessels of the brain, severe peripheral vascular disease, urgent revascularization procedures, heart failure, hepatotoxicity, liver failure, death"
77,ICLUSIG,warnings and precautions,"hypertension, high blood pressure, pancreatitis, neuropathy, peripheral neuropathy, cranial neuropathy, ocular toxicity, blindness, blurred vision, macular edema, retinal vein occlusion, retinal hemorrhage, conjunctival irritation, corneal irritation, dry eye, eye pain, cataracts, glaucoma, iritis, iridocyclitis, ulcerative keratitis, hemorrhage, serious bleeding, cerebral hemorrhage, gastrointestinal hemorrhage, fluid retention, brain edema, pericardial effusion, pleural effusion, ascites, peripheral edema, cardiac arrhythmias, bradyarrhythmias, pacemaker implantation, complete heart block, sick sinus syndrome, atrial fibrillation, bradycardia, supraventricular tachyarrhythmias, atrial flutter, supraventricular tachycardia, atrial tachycardia, myelosuppression, thrombocytopenia, neutropenia, anemia, tumor lysis syndrome, hyperuricemia, compromised wound healing, gastrointestinal perforation, fistula, embryo-fetal toxicity, fetal harm, death."
78,SABRIL,adverse reactions,"Vision Loss, Magnetic Resonance Imaging (MRI) Abnormalities in Infants, Neurotoxicity, Suicidal Behavior and Ideation, Withdrawal of Antiepileptic Drugs (AEDs), Anemia, Somnolence and Fatigue, Peripheral Neuropathy, Weight Gain, Edema, permanent vision loss, fatigue, somnolence, nystagmus, tremor, vision blurred, memory impairment, arthralgia, abnormal coordination, confusional state, increased weight, upper respiratory tract infection, aggression, diplopia, bronchitis, ear infection, otitis media acute, headache, dizziness, convulsion, nasopharyngitis, visual field defect, depression, nausea, diarrhea, insomnia, irritability, coordination abnormal, vomiting, influenza, pyrexia, rash, tinnitus, vertigo, asthenopia, eye pain, abdominal pain upper, dyspepsia, stomach discomfort, abdominal pain, toothache, abdominal distension, gait disturbance, asthenia, oedema peripheral, fever, chest pain, thirst, malaise, contusion, joint sprain, muscle strain, wound secretion, increased appetite, back pain, pain in extremity, myalgia, muscle twitching, muscle spasms, disturbance in attention, sensory disturbance, hyporeflexia, paraesthesia, lethargy, hyperreflexia, hypoaesthesia, sedation, status epilepticus, dysarthria, postictal state, sensory loss, irritability, anxiety, depressed mood, thinking abnormal, abnormal behaviour, expressive language disorder, nervousness, abnormal dreams, dysmenorrhoea, erectile dysfunction, pharyngolaryngeal pain, cough, pulmonary congestion, sinus headache, strabismus, conjunctivitis, viral infection, pneumonia, candidiasis, gastroenteritis viral, sinusitis, urinary tract infection, croup infectious, decreased appetite, sedation, status epilepticus, lethargy, convulsion, hypotonia, irritability, insomnia, nasal congestion, rash, congenital cardiac defects, congenital external ear anomaly, congenital hemangioma, congenital hydronephrosis, congenital male genital malformation, congenital oral malformation, congenital vesicoureteric reflux, dentofacial anomaly, dysmorphism, fetal anticonvulsant syndrome, hamartomas, hip dysplasia, limb malformation, limb reduction defect, low set ears, renal aplasia, retinitis pigmentosa, supernumerary nipple, talipes, deafness, delayed puberty, gastrointestinal hemorrhage, esophagitis, developmental delay, facial edema, malignant hyperthermia, multi-organ failure, cholestasis, dystonia, encephalopathy, hypertonia, muscle spasticity, myoclonus, optic neuritis, dyskinesia, acute psychosis, apathy, delirium, hypomania, neonatal agitation, psychotic disorder, laryngeal edema, pulmonary embolism, respiratory failure, stridor, angioedema, maculo-papular rash, pruritus, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)"
79,SABRIL,boxed warnings,"permanent bilateral concentric visual field constriction, tunnel vision, decrease in visual acuity, vision loss, severe vision loss, irreversible vision loss, retinopathy, glaucoma, worsening vision loss, death"
80,SABRIL,warnings and precautions,"Permanent vision loss, Abnormal MRI signal changes, Suicidal behavior and ideation, Withdrawal seizures, Anemia, Somnolence, Fatigue, Peripheral Neuropathy, Weight Gain, Edema"
81,VPRIV,adverse reactions,"hypersensitivity reactions, headache, dizziness, abdominal pain, nausea, back pain, joint pain, prolonged activated PTT, fatigue, asthenia, pyrexia, bone pain, tachycardia, rash, urticaria, flushing, hypertension, hypotension"
82,VPRIV,warnings and precautions,"hypersensitivity reactions, anaphylaxis, headache, dizziness, hypotension, hypertension, nausea, fatigue, asthenia, pyrexia, body temperature increased, chest discomfort, dyspnea, pruritus"
83,DALIRESP,adverse reactions,"Psychiatric Events Including Suicidality, Weight Decrease, Diarrhea, Nausea, Headache, Back Pain, Influenza, Insomnia, Dizziness, Decreased Appetite, Atrial Fibrillation, Lung Cancer, Prostate Cancer, Acute Pancreatitis, Acute Renal Failure, Abdominal Pain, Dyspepsia, Gastritis, Vomiting, Rhinitis, Sinusitis, Urinary Tract Infection, Muscle Spasms, Tremor, Anxiety, Depression, Hypersensitivity Reactions Including Angioedema, Urticaria, Rash"
84,DALIRESP,warnings and precautions,"acute bronchospasm, psychiatric events, suicidality, insomnia, anxiety, depression, suicidal thoughts, mood changes, weight decrease, weight loss, moderate weight loss, severe weight loss, death"
85,SYLVANT,adverse reactions,"severe infections, infusion-related reactions, hypersensitivity, pruritus, increased weight, rash, hyperuricemia, upper respiratory tract infection, rash generalized, rash maculo-papular, rash popular, rash pruritic, skin hyperpigmentation, eczema, psoriasis, dry skin, lower respiratory tract infection, thrombocytopenia, edema, constipation, hypertriglyceridemia, hypercholesterolemia, oropharyngeal pain, renal impairment, headache, hypotension, abdominal pain, abdominal distension, decreased appetite, dehydration, peripheral edema, diarrhea, pain in extremities, arthralgia, fatigue, anaphylaxis, back pain, chest pain, nausea, vomiting, flushing, erythema, palpitations"
86,SYLVANT,warnings and precautions,"severe infections, infections, Infusion Related Reactions, anaphylaxis, Gastrointestinal (GI) perforation"
87,LASTACAFT,adverse reactions,"eye irritation, burning and/or stinging on instillation, eye redness, eye pruritus, nasopharyngitis, headache, eye discharge, eye swelling, erythema of eyelid, eyelid edema, hypersensitivity, somnolence"
88,LASTACAFT,warnings and precautions,"eye injury, contamination, contact lens-related irritation"
89,GAZYVA,adverse reactions,"Hepatitis B reactivation, Progressive multifocal leukoencephalopathy, Infusion reactions, Tumor lysis syndrome, Infections, Neutropenia, Thrombocytopenia, Anemia, Pyrexia, Cough, Nausea, Diarrhea, Urinary tract infection, Back pain, Nasopharyngitis, Lymphopenia, Leukopenia, Hypocalcemia, Hyperkalemia, Hyponatremia, AST (SGOT increased), Creatinine increased, ALT (SGPT increased), Hypoalbuminemia, Alkaline phosphatase increased, Hypokalemia, Musculoskeletal disorders, Liver enzyme elevations, Immunogenicity, Worsening of Pre-existing Cardiac Conditions, death"
90,GAZYVA,boxed warnings,"Hepatitis B Virus reactivation, fulminant hepatitis, hepatic failure, death, Progressive Multifocal Leukoencephalopathy (PML)"
91,GAZYVA,warnings and precautions,"infusion reactions, tumor lysis syndrome, neutropenia, thrombocytopenia, immunization complications, hepatitis B virus reactivation, fulminant hepatitis, hepatic failure, death, progressive multifocal leukoencephalopathy (PML), acute renal failure, hyperkalemia, hypocalcemia, hyperuricemia, hyperphosphatemia, serious bacterial infections, serious fungal infections, new or reactivated viral infections, fatal infections, late onset neutropenia, prolonged neutropenia, antimicrobial prophylaxis, antiviral prophylaxis, antifungal prophylaxis, acute thrombocytopenia, fatal hemorrhagic events, hemorrhagic events, blood product transfusion, live virus vaccines, B-cell recovery"
92,ONGLYZA,adverse reactions,"upper respiratory tract infection, urinary tract infection, headache, peripheral edema, lymphopenia, rash, blood creatinine increased, blood creatine phosphokinase increased, sinusitis, abdominal pain, gastroenteritis, vomiting, hypoglycemia, urticaria, facial edema, tuberculosis, salmonella sepsis (death), anaphylaxis, angioedema, exfoliative skin conditions, acute pancreatitis, severe and disabling arthralgia"
93,ONGLYZA,warnings and precautions,"acute pancreatitis, hypoglycemia, hypersensitivity-related events, urticaria, facial edema, anaphylaxis, angioedema, exfoliative skin conditions, arthralgia, severe joint pain, severe and disabling arthralgia"
94,SIVEXTRO,adverse reactions,"nausea, headache, diarrhea, vomiting, dizziness, anemia, palpitations, tachycardia, asthenopia, vision blurred, visual impairment, vitreous floaters, infusion-related reactions, drug hypersensitivity, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, white blood cell count decreased, hypoesthesia, paresthesia, VIIth nerve paralysis, insomnia, pruritus, urticaria, dermatitis, flushing, hypertension, myelosuppression, peripheral neuropathy, optic neuropathy"
95,SIVEXTRO,warnings and precautions,"neutropenia, Clostridium difficile-associated diarrhea, CDAD, mild diarrhea, fatal colitis, death"
96,PREPOPIK,adverse reactions,"nausea, headache, vomiting, electrolyte abnormalities, potassium (low), sodium (low), chloride (low), magnesium (high), calcium (low), creatinine (high), eGFR (low), allergic reactions, rash, urticaria, purpura, hypokalemia, hyponatremia, hypermagnesemia, abdominal pain, diarrhea, fecal incontinence, proctalgia, reversible aphthoid ileal ulcers, ischemic colitis, generalized tonic-clonic seizures"
97,PREPOPIK,warnings and precautions,"fluid and electrolyte abnormalities, arrhythmia, seizures, renal impairment, mucosal ulcerations, GI obstruction, perforation, aspiration, orthostatic changes, cardiac arrhythmias, generalized tonic-clonic seizures, hyponatremia, hypokalemia, hypocalcemia, hypomagnesemia, renal injury, colonic mucosal aphthous ulcerations, ischemic colitis, ulcerative colitis, nausea, vomiting, dehydration, electrolyte disturbances"
98,OFEV,adverse reactions,"Liver Enzyme and Bilirubin Elevations, Gastrointestinal Disorders, Embryofetal Toxicity, Arterial Thromboembolic Events, Risk of Bleeding, Gastrointestinal Perforation, diarrhea, nausea, abdominal pain, vomiting, liver enzyme elevation, decreased appetite, headache, weight decreased, hypertension, bronchitis, myocardial infarction, pneumonia, lung neoplasm malignant, hypothyroidism, death"
99,OFEV,warnings and precautions,"elevated liver enzymes, ALT elevations, AST elevations, bilirubin elevations, gastrointestinal disorders, diarrhea, nausea, vomiting, embryofetal toxicity, arterial thromboembolic events, bleeding events, gastrointestinal perforation"
100,ZONTIVITY,adverse reactions,"Bleeding, life-threatening bleeding, fatal bleeding, death, GUSTO severe bleeding, intracranial bleeding, bleeding with hemodynamic compromise requiring intervention, GUSTO moderate bleeding, bleeding requiring transfusion, non-CABG-related bleeds, fatal bleeding, intracranial hemorrhage (ICH), clinically significant bleeding, gastrointestinal bleeding, anemia, depression, rashes, eruptions, exanthemas, iron deficiency, retinopathy or retinal disorder, diplopia, oculomotor disturbances"
101,ZONTIVITY,boxed warnings,"bleeding, stroke, transient ischemic attack, intracranial hemorrhage, active pathological bleeding, fatal bleeding, death"
102,ZONTIVITY,warnings and precautions,"bleeding, ICH (intracranial hemorrhage), fatal bleeding, death"
103,BELVIQ,adverse reactions,"Serotonin Syndrome, NMS-like Reactions, Valvular Heart Disease, Cognitive Impairment, Psychiatric Disorders, Hypoglycemia, Heart Rate Decreases, Hematological Changes, Prolactin Elevation, headache, dizziness, fatigue, nausea, dry mouth, constipation, back pain, cough, diarrhea, vomiting, upper respiratory tract infection, nasopharyngitis, urinary tract infection, musculoskeletal pain, oropharyngeal pain, sinus congestion, rash, toothache, peripheral edema, seasonal allergy, gastroenteritis, worsening of diabetes mellitus, decreased appetite, muscle spasms, anxiety, insomnia, stress, depression, suicidality, lymphocyte count decrease, neutrophil count decrease, hemoglobin decrease, eye disorders, blurred vision, dry eye, visual impairment, visual disorders, conjunctival infections, ocular sensation disorders, cataract conditions, valvular regurgitation, euphoria, serotonin syndrome, tremor, confusional state, disorientation, hyperhidrosis, hypertension."
104,BELVIQ,warnings and precautions,"Serotonin Syndrome, Neuroleptic Malignant Syndrome (NMS)-like Reactions, Valvular heart disease, Cognitive Impairment, Psychiatric Disorders, euphoria, dissociation, depression, suicidal thoughts, hypoglycemia, Priapism, Heart Rate Decreases, bradycardia, Hematological Changes, leukopenia, lymphopenia, neutropenia, anemia, Prolactin Elevation, galactorrhea, gynecomastia, Pulmonary Hypertension, death"
105,STELARA,adverse reactions,"Infections, Malignancies, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), Nasopharyngitis, Upper respiratory tract infection, Headache, Fatigue, Diarrhea, Back pain, Dizziness, Pharyngolaryngeal pain, Pruritus, Injection site erythema, Myalgia, Depression, Cellulitis, Herpes zoster, Diverticulitis, Injection site reactions (pain, swelling, pruritus, induration, hemorrhage, bruising, irritation), Arthralgia, Nausea, Dental infections, Serious hypersensitivity reactions (including anaphylaxis and angioedema), Other hypersensitivity reactions (including rash and urticaria), Pustular psoriasis, Erythrodermic psoriasis"
106,STELARA,warnings and precautions,"serious infections, infections, reactivation of latent infections, serious bacterial infections, fungal infections, viral infections, diverticulitis, cellulitis, pneumonia, appendicitis, cholecystitis, sepsis, osteomyelitis, gastroenteritis, urinary tract infections, disseminated infections, mycobacteria infections, salmonella infections, Bacillus Calmette-Guerin (BCG) vaccinations, tuberculosis, malignancy, anaphylaxis, hypersensitivity reactions, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), headache, seizures, confusion, visual disturbances, acute hypertension, immunosuppressive therapy, death"
107,NATROBA,adverse reactions,"application site erythema, ocular erythema, application site irritation, application site dryness, application site exfoliation, alopecia, dry skin"
108,NATROBA,warnings and precautions,"Benzyl alcohol toxicity, serious adverse reactions, death"
109,ELELYSO,adverse reactions,"pruritus, flushing, headache, arthralgia, pain in extremity, abdominal pain, vomiting, fatigue, back pain, dizziness, nausea, rash, urticaria, hypersensitivity reactions, severe vomiting, gastrointestinal inflammation, throat irritation, chest discomfort, anaphylaxis, immune-mediated fixed drug eruption, death"
110,ELELYSO,warnings and precautions,"hypersensitivity reactions, anaphylaxis, urticaria, hypotension, flushing, wheezing, chest tightness, nausea, vomiting, dizziness, pruritus, angioedema, erythema, rash, cough, throat irritation"
111,STRIVERDI,adverse reactions,"asthma-related death, nasopharyngitis, upper respiratory tract infection, bronchitis, urinary tract infection, cough, dizziness, rash, diarrhea, back pain, arthralgia, COPD exacerbation, pneumonia, atrial fibrillation, constipation, pyrexia, lung cancer, death"
112,STRIVERDI,boxed warnings,asthma-related death
113,STRIVERDI,warnings and precautions,"clinically significant cardiovascular effects, fatal, life-threatening paradoxical bronchospasm, asthma-related death, deterioration of disease, acute episodes of bronchospasm, excessive use of STRIVERDI RESPIMAT, fatalities, paradoxical bronchospasm, increases in pulse rate, systolic or diastolic blood pressure, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, aggravate pre-existing diabetes mellitus, ketoacidosis, significant hypokalemia, increases in plasma glucose, cardiac arrhythmias, angioedema, immediate hypersensitivity reactions, death"
114,BELSOMRA,adverse reactions,"CNS depressant effects, daytime impairment, abnormal thinking, behavioral changes, worsening of depression, suicidal ideation, sleep paralysis, hypnagogic/hypnopompic hallucinations, cataplexy-like symptoms, somnolence, diarrhea, dry mouth, upper respiratory tract infection, headache, dizziness, abnormal dreams, cough, increase in serum cholesterol"
115,BELSOMRA,warnings and precautions,"Daytime somnolence, impaired alertness, motor coordination impairment, impaired driving, insomnia persistence, ""sleep-driving"", complex behaviors while not fully awake, depression, worsening of depression, suicidal thinking, compromised respiratory function, sleep paralysis, hypnagogic/hypnopompic hallucinations, cataplexy-like symptoms, CNS depressant effects, daytime impairment, amnesia, anxiety, hallucinations, neuro-psychiatric symptoms, suicidal ideation, worsening of depression, suicidal thoughts, completed suicides, compromised respiratory function, inability to move or speak (sleep paralysis), vivid and disturbing perceptions (hypnagogic/hypnopompic hallucinations), leg weakness."
116,NPLATE,adverse reactions,"arthralgia, dizziness, insomnia, myalgia, pain in extremity, abdominal pain, shoulder pain, dyspepsia, paresthesia, headache, bone marrow reticulin deposition, worsening thrombocytopenia, erythromelalgia, hypersensitivity, angioedema"
117,NPLATE,warnings and precautions,"progression to acute myelogenous leukemia, increased blast cell counts, thrombotic/thromboembolic complications, portal vein thrombosis, worsened thrombocytopenia, formation of neutralizing antibodies, bone marrow reticulin formation, risk for bone marrow fibrosis, marrow fibrosis with collagen, lack or loss of response to Nplate, hyporesponsiveness, failure to maintain a platelet response, cytopenias"
118,ORBACTIV,adverse reactions,"Hypersensitivity Reactions, Infusion related reactions, Clostridium difficile-associated diarrhea, Osteomyelitis, headache, nausea, vomiting, limb and subcutaneous abscesses, diarrhea, cellulitis, dizziness, Infusion site phlebitis, Infusion site reaction, Alanine aminotransferase increased, Aspartate aminotransferase increased, Tachycardia, anemia, eosinophilia, infusion site erythema, extravasation, induration, pruritis, rash, edema peripheral, hypersensitivity, osteomyelitis, total bilirubin increased, hyperuricemia, hypoglycemia, tenosynovitis, myalgia, bronchospasm, wheezing, urticaria, angioedema, erythema multiforme, pruritis, leucocytoclastic vasculitis, rash"
119,ORBACTIV,warnings and precautions,"bleeding, aPTT prolongation, PT prolongation, INR prolongation, hypersensitivity reactions, infusion-related reactions, Clostridium difficile-associated diarrhea (CDAD), osteomyelitis, death (if CDAD is fatal)"
120,MEKINIST,adverse reactions,"New Primary Malignancies, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Interstitial Lung Disease, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, rash, diarrhea, lymphedema, pyrexia, chills, fatigue, nausea, vomiting, abdominal pain, peripheral edema, cough, headache, arthralgia, night sweats, decreased appetite, constipation, myalgia, decreased left ventricular ejection fraction (LVEF), pneumonitis, renal failure, stomatitis, hypertension, dermatitis acneiform, dry skin, pruritus, paronychia, lymphedema, hemorrhage, bradycardia, xerostomia, folliculitis, rash pustular, cellulitis, rhabdomyolysis, dizziness, dysgeusia, vision blurred, dry eye, increased aspartate aminotransferase (AST), increased alanine aminotransferase (ALT), hypoalbuminemia, anemia, increased alkaline phosphatase, edema peripheral, erythema, oropharyngeal pain, back pain, muscle spasms, pain in extremity, dehydration, insomnia, urinary tract infection, vision blurred, transient blindness, stomatitis, pancreatitis, asthenia, skin papilloma, palmar-plantar erythrodysesthesia syndrome, hyperkeratosis, hyperhidrosis, leukopenia, lymphopenia, neutropenia, thrombocytopenia, hyperbilirubinemia, hyperglycemia, increased gamma-glutamyltransferase (GGT), hyponatremia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QTcF prolongation."
121,MEKINIST,warnings and precautions,"Tumor promotion in patients with BRAF wild-type melanoma, Hemolytic anemia, New primary malignancies, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Interstitial Lung Disease (ILD), Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Embryofetal Toxicity, death"
122,CYRAMZA,adverse reactions,"hemorrhage, arterial thromboembolic events, hypertension, infusion-related reactions, gastrointestinal perforation, impaired wound healing, reversible posterior leukoencephalopathy syndrome, proteinuria, nephrotic syndrome, thyroid dysfunction, anemia, intestinal obstruction, hyponatremia, headache, neutropenia, epistaxis, rash, fatigue, diarrhea, stomatitis/mucosal inflammation, decreased appetite, febrile neutropenia, thrombocytopenia, gastrointestinal hemorrhage events, hypoalbuminemia, lacrimation increased, peripheral edema, palmar-plantar erythrodysesthesia syndrome, death"
123,CYRAMZA,boxed warnings,"hemorrhage, gastrointestinal hemorrhage, severe hemorrhagic events, death, gastrointestinal perforation, impaired wound healing"
124,CYRAMZA,warnings and precautions,"arterial thromboembolic events, myocardial infarction, cardiac arrest, cerebrovascular accident, cerebral ischemia, death, hypertension, severe hypertension, hypertensive crisis, hypertensive encephalopathy, infusion-related reactions, rigors/tremors, back pain/spasms, chest pain, chills, flushing, dyspnea, wheezing, hypoxia, paresthesia, bronchospasm, supraventricular tachycardia, hypotension, gastrointestinal perforation, impaired wound healing, encephalopathy, ascites, hepatorenal syndrome, reversible posterior leukoencephalopathy syndrome, proteinuria, nephrotic syndrome, thyroid dysfunction, hypothyroidism, embryofetal toxicity, fetal harm, hemorrhage, gastrointestinal hemorrhage, severe bleeding, pulmonary hemorrhage."
125,RAXIBACUMAB,adverse reactions,"rash, pain in extremity, pruritus, somnolence, urticaria, clonus, dyspnea, anemia, leukopenia, lymphadenopathy, palpitations, vertigo, fatigue, infusion site pain, peripheral edema, blood amylase increased, blood creatine phosphokinase increased, prothrombin time prolonged, back pain, muscle spasms, syncope vasovagal, insomnia, flushing, hypertension"
126,RAXIBACUMAB,warnings and precautions,"infusion reactions, rash, urticaria, pruritus"
127,ARCALYST,adverse reactions,"Mycobacterium intracellulare infection, gastrointestinal bleeding, colitis, sinusitis, bronchitis, Streptococcus pneumoniae meningitis, death, injection-site reaction (ISR), upper respiratory infection, neutropenia, transient neutropenia"
128,ARCALYST,warnings and precautions,"serious infections, life-threatening infections, hypersensitivity reactions, bacterial meningitis, death, reactivation of latent tuberculosis, TB, atypical infections, opportunistic infections, malignancies, lipid profile changes"
129,RAPIVAB,adverse reactions,"diarrhea, Alanine Aminotransferase increase, Serum Glucose increase, Creatine Phosphokinase increase, Neutrophils decrease, constipation, insomnia, AST increased, hypertension, Stevens-Johnson Syndrome, exfoliative dermatitis, rash, abnormal behavior, hallucination"
130,RAPIVAB,warnings and precautions,"Stevens-Johnson syndrome, erythema multiforme, hallucinations, delirium, abnormal behavior, death"
131,FOLOTYN,adverse reactions,"Bone Marrow Suppression, Mucositis, Dermatologic Reactions, Tumor Lysis Syndrome, Hepatic Toxicity, Thrombocytopenia, Nausea, Fatigue, Pyrexia, Sepsis, Febrile Neutropenia, Dehydration, Dyspnea, Anemia, Constipation, Edema, Cough, Epistaxis, Vomiting, Neutropenia, Diarrhea, Anorexia, Hypokalemia, Rash, Pruritus, Pharyngolaryngeal Pain, Liver Function Test Abnormal, Abdominal Pain, Pain in Extremity, Back Pain, Leukopenia, Night Sweats, Asthenia, Tachycardia, Upper Respiratory Tract Infection, Cardiopulmonary Arrest, Pancytopenia, Toxic Epidermal Necrolysis, Death"
132,FOLOTYN,warnings and precautions,"thrombocytopenia, neutropenia, anemia, mucositis, dermatologic reactions, death, tumor lysis syndrome, hepatic toxicity, increased toxicity with renal impairment, embryo-fetal toxicity"
133,KRYSTEXXA,adverse reactions,"anaphylaxis, infusion reactions, gout flares, nausea, contusion, ecchymosis, nasopharyngitis, constipation, chest pain, vomiting, congestive heart failure exacerbation"
134,KRYSTEXXA,boxed warnings,"anaphylaxis, infusion reactions, delayed-type hypersensitivity reactions"
135,KRYSTEXXA,warnings and precautions,"anaphylaxis, wheezing, peri-oral edema, lingual edema, hemodynamic instability, rash, urticaria, infusion reactions, gout flares, congestive heart failure exacerbation"
136,NUCYNTA,adverse reactions,"Respiratory Depression, Interaction with Alcohol, Chronic Pulmonary Disease, Hypotensive Effects, Interactions with Other CNS Depressants, Drug abuse, addiction, dependence, Gastrointestinal Effects, Seizures, Serotonin Syndrome, nausea, dizziness, vomiting, somnolence, headache, constipation, dry mouth, dyspepsia, fatigue, feeling hot, nasopharyngitis, upper respiratory tract infection, urinary tract infection, decreased appetite, tremor, lethargy, insomnia, confusional state, abnormal dreams, anxiety, pruritus, hyperhidrosis, pruritus generalized, rash, hot flush, heart rate increased, heart rate decreased, visual disturbance, abdominal discomfort, impaired gastric emptying, irritability, edema, drug withdrawal syndrome, feeling drunk, hypersensitivity, gamma-glutamyltransferase increased, alanine aminotransferase increased, aspartate aminotransferase increased, involuntary muscle contractions, sensation of heaviness, hypoesthesia, paresthesia, disturbance in attention, sedation, dysarthria, depressed level of consciousness, memory impairment, ataxia, presyncope, syncope, coordination abnormal, seizure, euphoric mood, disorientation, restlessness, agitation, nervousness, thinking abnormal, urinary hesitation, pollakiuria, oxygen saturation decreased, cough, dyspnea, respiratory depression, urticaria, blood pressure decreased, diarrhea, headache, hallucination, suicidal ideation, panic attack, palpitations, anaphylaxis, angioedema, anaphylactic shock, death"
137,NUCYNTA,warnings and precautions,"misuse, abuse, addiction, respiratory depression, hypotension, sedation, coma, death, seizures, serotonin syndrome, withdrawal symptoms, impaired mental/physical abilities, accidental ingestion, hypotensive effect, increased intracranial pressure, gastrointestinal conditions, hepatic impairment, renal impairment"
138,ACTEMRA,adverse reactions,"upper respiratory tract infections, nasopharyngitis, headache, hypertension, increased ALT, injection site reactions, serious infections, pneumonia, urinary tract infection, cellulitis, herpes zoster, gastroenteritis, diverticulitis, sepsis, bacterial arthritis, opportunistic infections, gastrointestinal perforations, purulent peritonitis, lower GI perforation, fistula, abscess, infusion reactions, anaphylaxis, death, neutropenia, thrombocytopenia, elevated liver enzymes, liver enzyme abnormalities, lipids elevation, immunogenicity, malignancies, dizziness, bronchitis, rash, pruritus, urticaria, mouth ulceration, abdominal pain upper, gastritis, transaminase increased, weight increased, total bilirubin increased, leukopenia, edema peripheral, dyspnea, cough, conjunctivitis, nephrolithiasis, hypothyroidism, Stevens-Johnson Syndrome"
139,ACTEMRA,boxed warnings,"serious infections, hospitalization, death, active tuberculosis, pulmonary disease, extrapulmonary disease, latent tuberculosis, invasive fungal infections, candidiasis, aspergillosis, pneumocystis, bacterial infections, viral infections, opportunistic pathogens, tuberculosis (TB)"
140,ACTEMRA,warnings and precautions,"Serious Infections, Gastrointestinal (GI) perforation, Hypersensitivity reactions, Anaphylaxis, Death, Neutropenia, Thrombocytopenia, Elevated Liver Enzymes, Lipid Abnormalities, Malignancies, Demyelinating Disorders, Active Hepatic Disease, Hepatic Impairment"
141,VIIBRYD,adverse reactions,"Suicidal Thoughts and Behaviors in Children, Adolescents, and Young Adults, Serotonin Syndrome, Increased Risk of Bleeding, Activation of Mania or Hypomania, Discontinuation Syndrome, Seizures, Angle-Closure Glaucoma, Hyponatremia, diarrhea, nausea, vomiting, insomnia, abdominal pain, dyspepsia, flatulence, gastroenteritis, abdominal distension, headache, dizziness, somnolence, paresthesia, abnormal dreams, restlessness, fatigue, palpitations, increased appetite, arthralgia, increased weight, abnormal orgasm, anorgasmia, erectile dysfunction, libido decreased, ejaculation disorder, ventricular extrasystoles, dry eye, vision blurred, cataracts, sedation, tremor, migraine, panic attack, hyperhidrosis, night sweats, irritability, hallucinations, suicide attempt, suicidal ideation, rash, generalized rash, urticaria, drug eruption, death"
142,VIIBRYD,boxed warnings,"suicidal thoughts, suicidal behaviors, clinical worsening"
143,VIIBRYD,warnings and precautions,"Serotonin Syndrome, Increased Risk of Bleeding, Activation of Mania/Hypomania, Seizures, Angle Closure Glaucoma, Suicidal Thoughts and Behavior, Discontinuation Syndrome, Hyponatremia"
144,LUZU,adverse reactions,"application site reactions, contact dermatitis, cellulitis"
145,LUMASON,adverse reactions,"severe cardiopulmonary reactions, hypersensitivity reactions, headache, nausea, hypersensitivity-type rash, near syncope symptoms, anaphylactic shock, dysgeusia, injection site pain, chest discomfort, feeling hot, chest pain, injection site warmth, fatalities, arrhythmias, hypertensive episodes, death"
146,LUMASON,boxed warnings,"serious cardiopulmonary reactions, fatalities, death"
147,LUMASON,warnings and precautions,"cardiopulmonary reactions, death, anaphylactoid reactions, fatal cardiac arrest, respiratory arrest, shock, syncope, symptomatic arrhythmias, atrial fibrillation, tachycardia, bradycardia, supraventricular tachycardia, ventricular fibrillation, ventricular tachycardia, hypertension, hypotension, dyspnea, hypoxia, chest pain, respiratory distress, stridor, wheezing, loss of consciousness, convulsions, skin erythema, rash, urticaria, flushing, throat tightness, anaphylactic shock, systemic embolization, tissue ischemia, ventricular arrhythmias"
148,LYNPARZA,adverse reactions,"Myelodysplastic syndrome, Acute Myeloid Leukemia, Pneumonitis, Anemia, Nausea, Fatigue, Asthenia, Vomiting, Diarrhea, Dysgeusia, Dyspepsia, Headache, Decreased appetite, Nasopharyngitis, Pharyngitis, Upper Respiratory Infection (URI), Cough, Arthralgia, Musculoskeletal pain, Myalgia, Back pain, Dermatitis, Rash, Abdominal pain, Discomfort, Increase in creatinine, Mean corpuscular volume elevation, Decrease in hemoglobin, Decrease in lymphocytes, Decrease in absolute neutrophil count, Decrease in platelets, COPD, Cerebrovascular accident, Intestinal perforation, Pulmonary embolism, Sepsis, Suture rupture, Death"
149,LYNPARZA,warnings and precautions,"Myelodysplastic syndrome/Acute Myeloid Leukemia (MDS/AML), death, Pneumonitis, death, Embryo-Fetal toxicity"
150,EGRIFTA,adverse reactions,"hypersensitivity, rash, urticaria, arthralgia, extremity pain, peripheral edema, hyperglycemia, carpal tunnel syndrome, injection site reactions, injection site erythema, pruritus, pain, irritation, swelling, hemorrhage, myalgia, musculoskeletal pain, musculoskeletal stiffness, joint stiffness, muscle spasms, joint swelling, chest pain, injection site rash, paresthesia, hypoesthesia, nausea, vomiting, dyspepsia, abdominal pain upper, palpitations, depression, night sweats, hypertension, muscle strain, blood creatine phosphokinase increased, diabetes, neuropathy peripheral, insomnia, hot flush"
151,EGRIFTA,warnings and precautions,"neoplasms, elevated IGF-1, fluid retention, edema, arthralgia, carpal tunnel syndrome, glucose intolerance, hypersensitivity reactions, rash, urticaria, injection site reactions, erythema, pruritus, pain, irritation, bruising, acute critical illness, increased mortality, diabetes, impaired glucose tolerance, worsening of retinopathy"
152,ELLA,adverse reactions,"headache, abdominal pain, nausea, dysmenorrhea, fatigue, dizziness, acne"
153,ELLA,warnings and precautions,"ectopic pregnancy, lower abdominal pain, altered menstrual cycle, delayed menses, intermenstrual bleeding"
154,ZALTRAP,adverse reactions,"Hemorrhage, Gastrointestinal Perforation, Compromised Wound Healing, Fistula Formation, Hypertension, Arterial Thromboembolic Events, Proteinuria, Neutropenia, Neutropenic Complications, Diarrhea, Dehydration, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), leukopenia, AST increased, stomatitis, fatigue, thrombocytopenia, ALT increased, weight decreased, decreased appetite, epistaxis, abdominal pain, dysphonia, serum creatinine increased, headache, asthenia, venous thromboembolic events, severe hypersensitivity reactions, deep venous thrombosis, pulmonary embolism, Urinary Tract Infection, Oropharyngeal Pain, Rhinorrhea, Dyspnea, Hemorrhoids, Rectal Hemorrhage, Proctalgia, Palmar-Plantar Erythrodysesthesia Syndrome, Skin Hyperpigmentation"
155,ZALTRAP,boxed warnings,"Hemorrhage, gastrointestinal hemorrhage, fatal hemorrhage, gastrointestinal perforation, fatal gastrointestinal perforation, compromised wound healing, severe bleeding, death"
156,ZALTRAP,warnings and precautions,"fistula formation, hypertension, hypertensive crisis, arterial thromboembolic events, transient ischemic attacks, cerebrovascular accident, angina pectoris, proteinuria, nephrotic syndrome, thrombotic microangiopathy, neutropenia, neutropenic complications, febrile neutropenia, neutropenic infection, sepsis, diarrhea, dehydration, reversible posterior leukoencephalopathy syndrome, hemorrhage, gastrointestinal hemorrhage, hematuria, post-procedural hemorrhage, intracranial hemorrhage, pulmonary hemorrhage, hemoptysis, gastrointestinal perforation, compromised wound healing, death"
157,MYRBETRIQ,adverse reactions,"hypertension, nasopharyngitis, urinary tract infection, headache, nausea, diarrhea, constipation, dizziness, tachycardia, atrial fibrillation, prostate cancer, upper respiratory tract infection, arthralgia, abdominal pain, fatigue, palpitations, blood pressure increased, glaucoma, dyspepsia, gastritis, abdominal distension, sinusitis, rhinitis, GGT increased, AST increased, ALT increased, LDH increased, nephrolithiasis, bladder pain, vulvovaginal pruritus, vaginal infection, urticaria, leukocytoclastic vasculitis, rash, pruritus, purpura, lip edema, back pain, dry mouth, sinusitis, influenza, cystitis, cerebrovascular accident, osteoarthritis, neoplasm, Stevens-Johnson syndrome, angioedema, urinary retention"
158,MYRBETRIQ,warnings and precautions,"Increases in Blood Pressure, Urinary Retention, Angioedema, Worsening of pre-existing hypertension, death (if angioedema involves upper airway swelling and becomes life-threatening)."
159,EDURANT,adverse reactions,"Skin and Hypersensitivity Reactions, Depressive Disorders, Hepatotoxicity, headache, insomnia, rash, psychiatric disorders, abdominal pain, nausea, vomiting, fatigue, dizziness, abnormal dreams, diarrhea, abdominal discomfort, cholecystitis, cholelithiasis, decreased appetite, somnolence, sleep disorders, anxiety, glomerulonephritis membranous, glomerulonephritis mesangioproliferative, nephrolithiasis, increased creatinine, increased AST, increased ALT, increased total bilirubin, increased total cholesterol, increased LDL cholesterol, increased triglycerides, adrenal function abnormalities, nephrotic syndrome, severe skin and hypersensitivity reactions including DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms)"
160,EDURANT,warnings and precautions,"Torsade de Pointes, Severe skin and hypersensitivity reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), rash with systemic symptoms, elevations in hepatic serum biochemistries, Severe depressive disorders, depressed mood, depression, dysphoria, major depression, mood altered, negative thoughts, suicide attempt, suicidal ideation, Hepatotoxicity, hepatic adverse events, worsening or development of transaminase elevations, hepatic toxicity, Redistribution/accumulation of body fat, Immune reconstitution syndrome, inflammatory response to infections, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome."
161,HARVONI,adverse reactions,"fatigue, headache, nausea, bilirubin elevations, lipase elevations"
162,HARVONI,warnings and precautions,"serious symptomatic bradycardia, fatal cardiac arrest, pacemaker intervention, near-fainting, fainting, dizziness, lightheadedness, malaise, weakness, excessive tiredness, shortness of breath, chest pains, confusion, memory problems, death"
163,OSPHENA,adverse reactions,"hot flush, vaginal discharge, muscle spasms, genital discharge, hyperhidrosis, thromboembolic stroke, hemorrhagic stroke, deep vein thrombosis (DVT), allergic conditions, hypersensitivity, angioedema, rash, rash erythematous, rash generalized, pruritus, urticaria"
164,OSPHENA,boxed warnings,"endometrial cancer, cardiovascular disorders, stroke, deep vein thrombosis (DVT), thromboembolic stroke, hemorrhagic stroke, endometrial hyperplasia"
165,OSPHENA,warnings and precautions,"Venous Thromboembolism, DVT, pulmonary embolism, Stroke, hemorrhagic stroke, Coronary Heart Disease, nonfatal MI, silent MI, CHD death, Endometrial Cancer, endometrial hyperplasia, Uterine polyps, Breast Cancer, Severe Hepatic Impairment"
166,ERIVEDGE,adverse reactions,"muscle spasms, alopecia, dysgeusia, weight loss, fatigue, nausea, diarrhea, decreased appetite, constipation, arthralgias, vomiting, ageusia, amenorrhea, hyponatremia, hypokalemia, azotemia"
167,ERIVEDGE,boxed warnings,"embryo-fetal death, severe birth defects, embryotoxic, fetotoxic, teratogenic, severe midline defects, missing digits, irreversible malformations, death"
168,ERIVEDGE,warnings and precautions,"embryo-fetal death, severe birth defects, embryotoxic, fetotoxic, teratogenic, death"
169,LATUDA,adverse reactions,"Increased Mortality in Elderly Patients with Dementia-Related Psychosis, Suicidal Thoughts and Behaviors, Cerebrovascular Adverse Reactions, Stroke, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hyperglycemia, Diabetes Mellitus, Dyslipidemia, Weight Gain, Hyperprolactinemia, Leukopenia, Neutropenia, Agranulocytosis, Orthostatic Hypotension, Syncope, Seizures, Cognitive Impairment, Motor Impairment, Body Temperature Dysregulation, Suicide, Activation of Mania/Hypomania, Dysphagia, Neurological Adverse Reactions in Patients with Parkinson's Disease, Dementia with Lewy Bodies, somnolence, akathisia, extrapyramidal symptoms, nausea, vomiting, diarrhea, anxiety, salivary hypersecretion, back pain, dizziness, insomnia, agitation, restlessness, dry mouth, nasopharyngitis, influenza, urinary tract infection, fatigue, increased appetite, weight increased, dystonia, parkinsonism, abnormal dreams, panic attack, sleep disorder, dysuria, renal failure, amenorrhea, dysmenorrhea, breast enlargement, breast pain, galactorrhea, erectile dysfunction, rash, pruritus, angioedema, hypertension, sudden death, death."
170,LATUDA,boxed warnings,"increased mortality, death, suicidal thoughts, suicidal behaviors"
171,LATUDA,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Hyperglycemia, Diabetes Mellitus, Dyslipidemia, Weight Gain, Hyperprolactinemia, Leukopenia, Neutropenia, Agranulocytosis, Orthostatic Hypotension, Syncope, death, suicidal thoughts and behaviors, seizures, cognitive and motor impairment, body temperature dysregulation, suicide, activation of mania/hypomania, Dysphagia, neurological adverse reactions in patients with Parkinson's Disease or Dementia with Lewy Bodies"
172,LEXISCAN,adverse reactions,"Myocardial Ischemia, Sinoatrial Block, Atrioventricular Nodal Block, Atrial Fibrillation, Atrial Flutter, Hypersensitivity, Anaphylaxis, Hypotension, Hypertension, Bronchoconstriction, Seizure, Cerebrovascular Accident, Stroke, Dyspnea, Headache, Flushing, Chest Discomfort, Dizziness, Angina Pectoris, Chest Pain, Nausea, Abdominal Discomfort, Dysgeusia, Feeling Hot, Rhythm Abnormalities, PACs, PVCs, First-degree AV Block, Second-degree AV Block, AV Conduction Abnormalities, Ventricular Conduction Abnormalities, Wheezing, FEV1 Reduction, Myocardial Infarction, Cardiac Arrest, Ventricular Arrhythmias, Supraventricular Tachyarrhythmias, Heart Block, Asystole, Transient Ischemic Attack, QTc Prolongation, Tremor, Transient Ischemic Attack, Intracranial Hemorrhage, Abdominal Pain, Vomiting, Myalgias, Diarrhea, Fecal Incontinence, Angioedema, Cardiac Arrest, Respiratory Arrest, Respiratory Distress, Decreased Oxygen Saturation, Throat Tightness, Urticaria, Rashes, Musculoskeletal Pain, Respiratory Arrest, Dyspnea, Wheezing, death"
173,LEXISCAN,warnings and precautions,"Myocardial Ischemia, Fatal cardiac events, death, Sinoatrial (SA) Nodal Block, Atrioventricular (AV) Nodal Block, first-degree AV block, second-degree AV block, third-degree AV block, sinus bradycardia, Atrial Fibrillation, Atrial Flutter, Hypersensitivity, Anaphylaxis, angioedema, cardiac arrest, respiratory arrest, respiratory distress, decreased oxygen saturation, hypotension, throat tightness, urticaria, rashes, Hypertension, Bronchoconstriction, dyspnea, respiratory compromise, Seizure, convulsive seizures, Cerebrovascular Accident, Stroke, Hemorrhagic stroke, ischemic stroke, ventricular arrhythmias, syncope, transient ischemic attacks."
174,BRILINTA,adverse reactions,"bleeding, dyspnea, fatal, life-threatening, intracranial hemorrhage, intrapericardial with cardiac tamponade, hypovolemic shock, severe hypotension requiring intervention, significantly disabling, intraocular with permanent vision loss, decrease in Hb, fall in hematocrit, transfusion of 2 or more units, transfusion of 4 or more units, dizziness, nausea, bradycardia, syncope, pre-syncope, loss of consciousness, gout, serum uric acid increase, serum creatinine increase, acute renal failure, chronic renal failure, toxic nephropathy, oliguria, diarrhea"
175,BRILINTA,boxed warnings,"significant bleeding, fatal bleeding, death, active pathological bleeding, intracranial hemorrhage, subsequent cardiovascular events"
176,BRILINTA,warnings and precautions,"dyspnea, severe hepatic impairment, risk of bleeding, myocardial infarction, stroke, death"
177,KERYDIN,adverse reactions,"application site exfoliation, ingrown toenail, application site erythema, application site dermatitis"
178,ZELBORAF,adverse reactions,"New Primary Malignancies, Hypersensitivity Reactions, Dermatologic Reactions, QT Prolongation, Hepatotoxicity, Photosensitivity, Ophthalmologic Reactions, Radiation Sensitization, Radiation Recall, arthralgia, rash, alopecia, fatigue, photosensitivity reaction, nausea, pruritus, skin papilloma, cuSCC, hyperkeratosis, rash maculo-papular, actinic keratosis, dry skin, rash papular, erythema, myalgia, pain in extremity, musculoskeletal pain, back pain, edema peripheral, pyrexia, asthenia, diarrhea, vomiting, constipation, headache, dysgeusia, cutaneous SCC, seborrheic keratosis, gamma-glutamyltransferase increased, decreased appetite, cough, sunburn, palmar-plantar erythrodysesthesia syndrome, keratosis pilaris, panniculitis, erythema nodosum, Stevens-Johnson syndrome, toxic epidermal necrolysis, arthritis, neuropathy peripheral, VIIth nerve paralysis, basal cell carcinoma, oropharyngeal squamous cell carcinoma, folliculitis, retinal vein occlusion, vasculitis, atrial fibrillation, GGT increase, AST increase, ALT increase, alkaline phosphatase increase, bilirubin increase, Progression of pre-existing chronic myelomonocytic leukemia, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), Neutropenia, Pancreatitis."
179,ZELBORAF,warnings and precautions,"New Primary Cutaneous Malignancies, New Non-Cutaneous Squamous Cell Carcinoma, Other Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Serious Hypersensitivity Reactions, Anaphylaxis, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome), Severe Dermatologic Reactions, Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, QT Prolongation, Hepatotoxicity, Photosensitivity, Serious Ophthalmologic Reactions, Uveitis, Embryo-Fetal Toxicity, Radiation Sensitization, Radiation Recall, Cutaneous Squamous Cell Carcinoma, Keratoacanthoma, Melanoma, Non-Cutaneous Squamous Cell Carcinoma, Liver Injury, Functional Hepatic Impairment, Coagulopathy, Organ Dysfunction, Mild to Severe Photosensitivity, Blurry Vision, Photophobia, Iritis"
180,FYCOMPA,adverse reactions,"Serious Psychiatric and Behavioral Reactions, Suicidal Behavior and Ideation, Dizziness, Gait Disturbance, Somnolence, Fatigue, Falls, Nausea, Weight Gain, Vertigo, Ataxia, Headache, Vomiting, Contusion, Abdominal Pain, Anxiety, Aggression, Anger, Blurred Vision, Dysarthria, Balance Disorder, Back Pain, Cough, Upper Respiratory Tract Infection, Hypersomnia, Limb Injury, Mood Altered, Arthralgia, Asthenia, Memory Impairment, Musculoskeletal Pain, Oropharyngeal Pain, Paraesthesia, Peripheral Edema, Skin Laceration, Euphoric Mood, Confusional State, Hyponatremia, Pain in Extremity, Constipation, Myalgia, Coordination Abnormal, Head Injury, Hypoaesthesia, Urinary Tract Infection, Ligament Sprain, Rash, Elevated Triglycerides, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)."
181,FYCOMPA,boxed warnings,"aggression, hostility, irritability, anger, homicidal ideation and threats, changes in mood, behavior, personality changes"
182,FYCOMPA,warnings and precautions,"suicidal thoughts or behavior, suicidal ideation, hostility, aggression, anger, anxiety, irritability, belligerence, affect lability, agitation, physical assault, homicidal ideation, homicidal threat, paranoia, euphoric mood, mental status changes, disorientation, confusional state, delusion, dizziness, gait disturbance, somnolence, fatigue, falls, injuries, head injuries, bone fracture, increased seizure frequency, withdrawal symptoms"
183,ISTODAX,adverse reactions,"Myelosuppression, Infection, Electrocardiographic Changes, Tumor Lysis Syndrome, Neutropenia, Lymphopenia, Thrombocytopenia, Nausea, Fatigue, Vomiting, Anorexia, Anemia, ECG T-wave changes, Asthenia, Hypomagnesemia, Diarrhea, Pyrexia, Dysgeusia, Constipation, Hypotension, Pruritus, Hypokalemia, Dermatitis, Exfoliative dermatitis, Hypocalcemia, Leukopenia, Alanine aminotransferase increased, Aspartate aminotransferase increased, Hypoalbuminemia, Electrocardiogram ST-T wave changes, Hyperglycemia, Hyponatremia, Hypermagnesemia, Hypophosphatemia, Hyperuricemia, Sepsis, Supraventricular arrhythmia, Central line infection, Edema, Ventricular arrhythmia, Dehydration, Catheter related infection, Dyspnea, Gastrointestinal disorders, Abdominal pain, Stomatitis, General disorders and administration site conditions, Chills, Edema peripheral, Blood and lymphatic system disorders, Metabolism and nutrition disorders, Nervous system disorders, Headache, Respiratory, thoracic and mediastinal disorders, Cough, Investigations, Weight decreased, Cardiac disorders, Tachycardia, Pneumonia, Cellulitis, Deep vein thrombosis, Febrile neutropenia, Chest pain, Pulmonary embolism, Hyperbilirubinemia, Hypoxia, Hypersensitivity, Packed red blood cell transfusion, Platelet transfusion, Reactivation of hepatitis B virus infection, Multi-organ failure, Septic shock, Candida sepsis, Cardiogenic shock, Epstein Barr virus reactivation, QT prolongation, death"
184,ISTODAX,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, fatal infections, serious infections, pneumonia, sepsis, viral reactivation, Epstein Barr virus reactivation, hepatitis B virus reactivation, liver failure, ECG changes, T-wave changes, ST-segment changes, QT prolongation, tumor lysis syndrome (TLS), fetal harm, embryocidal effects, death"
185,ZIOPTAN,adverse reactions,"conjunctival hyperemia, ocular stinging/irritation, ocular pruritus, allergic conjunctivitis, cataract, dry eye, ocular pain, eyelash darkening, growth of eyelashes, vision blurred, headache, common cold, cough, urinary tract infection, exacerbation of asthma, dyspnea, iritis/uveitis, deepening of the eyelid sulcus"
186,ZIOPTAN,warnings and precautions,"Pigmentation of the iris, periorbital tissue pigmentation, eyelash pigmentation, increased length of eyelashes, increased thickness of eyelashes, increased number of eyelashes, iris color change, intraocular inflammation, macular edema, cystoid macular edema."
187,SIGNIFOR,adverse reactions,"hypocortisolism, hyperglycemia, diabetes mellitus, bradycardia, QT prolongation, liver test elevations, cholelithiasis, pituitary hormone deficiency, diarrhea, nausea, headache, abdominal pain, fatigue, injection site reactions, nasopharyngitis, alopecia, asthenia, glycosylated hemoglobin increased, alanine aminotransferase increased, gamma-glutamyl transferase increased, edema peripheral, abdominal pain upper, decreased appetite, hypercholesterolemia, hypertension, dizziness, hypoglycemia, type 2 diabetes mellitus, anxiety, influenza, insomnia, myalgia, arthralgia, pruritus, lipase increased, constipation, hypotension, vomiting, back pain, dry skin, electrocardiogram QT prolonged, hypokalemia, pain in extremity, sinus bradycardia, vertigo, abdominal distension, adrenal insufficiency, aspartate aminotransferase increased, blood glucose increased, anemia, blood amylase increased, prothrombin time prolonged, pancreatitis, hypothyroidism, thrombocytopenia, leukopenia, neutropenia, anemia, lymphopenia, hemoglobin decreased, PT increased, PTT increased"
188,SIGNIFOR,warnings and precautions,"hypocortisolism, biochemical hypocortisolism, clinical hypocortisolism, hyperglycemia, diabetes, bradycardia, QT prolongation, liver test elevations, cholelithiasis, deficiency of pituitary hormones"
189,SOVALDI,adverse reactions,"Serious Symptomatic Bradycardia, fatigue, headache, nausea, insomnia, anemia, pruritus, asthenia, rash, decreased appetite, chills, influenza like illness, pyrexia, diarrhea, neutropenia, myalgia, irritability, pancytopenia, severe depression, suicidal ideation, suicide, hematologic effects, laboratory abnormalities, bilirubin elevations, creatine kinase elevations, lipase elevations, cardiac disorders, death"
190,SOVALDI,warnings and precautions,"serious symptomatic bradycardia, pacemaker intervention, fatal cardiac arrest, death, near-fainting, fainting, dizziness, lightheadedness, malaise, weakness, excessive tiredness, shortness of breath, chest pains, confusion, memory problems"
191,OLYSIO,adverse reactions,"Serious Symptomatic Bradycardia, Hepatic Decompensation, Hepatic Failure, Photosensitivity, Rash, Pruritus, Nausea, Fatigue, Headache, Myalgia, Dyspnea, Alkaline phosphatase elevation, Hyperbilirubinemia, Insomnia, Dizziness, Diarrhea"
192,OLYSIO,warnings and precautions,"serious symptomatic bradycardia, symptomatic bradycardia, bradycardia, pacemaker intervention, cardiac arrest, death, hepatic decompensation, hepatic failure, photosensitivity reactions, rash, severe rash, hospitalization, burning, erythema, exudation, blistering, edema, fatigue, weakness, lack of appetite, nausea and vomiting, jaundice, discolored feces, adverse reactions, reduced therapeutic effect"
193,PLEGRIDY,adverse reactions,"Hepatic Injury, Depression, Suicide, Seizures, Anaphylaxis, Allergic Reactions, Injection Site Reactions, Congestive Heart Failure, Decreased Peripheral Blood Counts, Autoimmune Disorders, injection site erythema, influenza-like illness, pyrexia, headache, myalgia, chills, injection site pain, asthenia, injection site pruritus, arthralgia, Nausea, Vomiting, Hyperthermia, Pain, Injection site edema, Injection site warmth, Injection site hematoma, Injection site rash, Body temperature increased, Alanine aminotransferase increased, Aspartate aminotransferase increased, Gamma-glutamyl-transferase increased, Pruritus"
194,PLEGRIDY,warnings and precautions,"hepatic injury, hepatitis, autoimmune hepatitis, severe hepatic failure, asymptomatic elevation of hepatic transaminases, elevation of hepatic enzymes, elevation of alanine aminotransferase, elevation of aspartate aminotransferase, depression, suicidal ideation, suicide, seizures, anaphylaxis, serious allergic reactions, angioedema, urticaria, injection site reactions, injection site necrosis, congestive heart failure, cardiomyopathy, decreased peripheral blood counts, pancytopenia, severe thrombocytopenia, white blood cell count decrease, lymphocyte count decrease, neutrophil count decrease, platelet count decrease, infections, bleeding, anemia, autoimmune disorders, idiopathic thrombocytopenia, hyperthyroidism, hypothyroidism"
195,VIBATIV,adverse reactions,"Nephrotoxicity, Infusion-related reactions, Clostridium difficile-associated diarrhea, Diarrhea, Taste disturbance, Nausea, Vomiting, Foamy urine, Death, Rigors, Decreased appetite, Renal System, Renal Failure Acute, Renal impairment, Renal insufficiency, Renal failure, Increased serum creatinine, Serious hypersensitivity reactions, Anaphylactic reactions."
196,VIBATIV,boxed warnings,"increased mortality, death, nephrotoxicity, new onset renal impairment, worsening renal impairment, adverse developmental outcomes"
197,VIBATIV,warnings and precautions,"decreased efficacy, hypersensitivity reactions, anaphylactic reactions, death, infusion-related reactions, Clostridium difficile-associated disease, mild diarrhea, fatal colitis, coagulation test interference, QTc prolongation, increased mortality, nephrotoxicity, renal adverse events, drug-resistant bacteria, superinfection"
198,KIT,adverse reactions,"injection site irritation, pain"
199,KIT,warnings and precautions,"hypersensitivity reactions, serious hypersensitivity reactions, cancer, excessive radiation exposure"
200,HETLIOZ,adverse reactions,"headache, increased alanine aminotransferase, nightmares or unusual dreams, upper respiratory tract infection, urinary tract infection"
201,HETLIOZ,warnings and precautions,"somnolence, impairment of mental alertness"
202,VOTRIENT,adverse reactions,"diarrhea, hypertension, hair color changes, nausea, anorexia, vomiting, fatigue, decreased weight, decreased appetite, tumor pain, dysgeusia, headache, musculoskeletal pain, myalgia, gastrointestinal pain, dyspnea, hepatotoxicity, QT prolongation, torsades de pointes, cardiac dysfunction, hemorrhagic events, arterial thromboembolic events, venous thromboembolic events, thrombotic microangiopathy, gastrointestinal perforation, fistula, interstitial lung disease, pneumonitis, reversible posterior leukoencephalopathy syndrome, infection, increased toxicity with other cancer therapies, asthenia, abdominal pain, alopecia, chest pain, dyspepsia, dysphonia, facial edema, palmar-plantar erythrodysesthesia, proteinuria, rash, skin depigmentation, weight decreased, arthralgia, muscle spasms, leukopenia, neutropenia, thrombocytopenia, lymphocytopenia, ALT increased, AST increased, glucose increased, total bilirubin increased, phosphorus decreased, sodium decreased, magnesium decreased, glucose decreased, exfoliative rash, cough, peripheral edema, mucositis, dizziness, skin disorder, skin hypopigmentation, stomatitis, insomnia, hypothyroidism, epistaxis, left ventricular dysfunction, dry skin, chills, vision blurred, nail disorder, lipase elevations, pancreatitis, pneumothorax, bradycardia, retinal detachment/tear."
203,VOTRIENT,boxed warnings,"hepatotoxicity, severe hepatotoxicity, fatal hepatotoxicity, death"
204,VOTRIENT,warnings and precautions,"hepatotoxicity, death, serum transaminase levels increase, bilirubin increase, QT interval prolongation, torsades de pointes, cardiac dysfunction, congestive heart failure, decreased left ventricular ejection fraction (LVEF), hemorrhagic events, arterial thromboembolic events, venous thromboembolic events (VTE), pulmonary emboli (PE), thrombotic microangiopathy (TMA), thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), gastrointestinal perforation, fistula, interstitial lung disease (ILD), pneumonitis, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), hypertension, hypertensive crisis, hypothyroidism, proteinuria, infection, wound healing complications, fetal harm"
205,JAKAFI,adverse reactions,"Thrombocytopenia, Anemia, Neutropenia, Risk of Infection, Symptom Exacerbation Following Interruption or Discontinuation of Treatment, Non-Melanoma Skin Cancer, Bruising, Dizziness, Headache, Urinary Tract Infections, Weight Gain, Flatulence, Herpes Zoster, Alanine Transaminase (ALT) elevation, Aspartate Transaminase (AST) elevation, Cholesterol elevation, Abdominal Pain, Diarrhea, Fatigue, Pruritus, Dyspnea, Muscle Spasms, Nasopharyngitis, Constipation, Cough, Edema, Arthralgia, Asthenia, Epistaxis, Nausea, Hypertension, Hypercholesterolemia, Hypertriglyceridemia"
206,JAKAFI,warnings and precautions,"Thrombocytopenia, Anemia, Neutropenia, Risk of Infection, Serious bacterial infections, Mycobacterial infections, Fungal infections, Viral infections, Tuberculosis, Progressive multifocal leukoencephalopathy (PML), Herpes Zoster, Symptom Exacerbation Following Interruption or Discontinuation, Fever, Respiratory distress, Hypotension, Disseminated intravascular coagulation (DIC), Multi-organ failure, Non-Melanoma Skin Cancer, Basal cell carcinoma, Squamous cell carcinoma, Merkel cell carcinoma."
207,AKYNZEO,adverse reactions,"headache, asthenia, dyspepsia, fatigue, constipation, erythema, elevations of transaminases, total bilirubin"
208,AKYNZEO,warnings and precautions,"hypersensitivity reactions, anaphylaxis, serotonin syndrome, mental status changes, agitation, hallucinations, delirium, coma, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, nausea, vomiting, diarrhea, death"
209,VIEKIRA,adverse reactions,"Increased Risk of ALT Elevations, fatigue, nausea, pruritus, other skin reactions, insomnia, asthenia, serious adverse event (SAE), dyspnea, anemia/decreased hemoglobin, ocular icterus, headache, cough, irritability, hyperbilirubinemia, jaundice, diarrhea, muscle spasms, rash, hypersensitivity reactions (including angioedema), death"
210,VIEKIRA,warnings and precautions,"ALT elevations, fatigue, weakness, lack of appetite, nausea and vomiting, jaundice, discolored feces, liver inflammation, increased conjugated bilirubin, increased alkaline phosphatase, increased INR, loss of therapeutic effect of VIEKIRA PAK, development of resistance, clinically significant adverse reactions, HIV-1 protease inhibitor drug resistance"
211,PERJETA,adverse reactions,"Left Ventricular Dysfunction, Embryo-Fetal Toxicity, Infusion-Related Reactions, Hypersensitivity Reactions, Anaphylaxis, Diarrhea, Alopecia, Neutropenia, Nausea, Fatigue, Rash, Peripheral Neuropathy, Febrile Neutropenia, Leukopenia, Anemia, Asthenia, Edema Peripheral, Mucosal Inflammation, Pyrexia, Nail Disorder, Pruritus, Dry Skin, Vomiting, Constipation, Stomatitis, Headache, Dysgeusia, Dizziness, Myalgia, Arthralgia, Upper Respiratory Tract Infection, Nasopharyngitis, Dyspnea, Decreased Appetite, Lacrimation Increased, Insomnia, Paronychia, Pleural Effusion, Left Ventricular Dysfunction (including symptomatic left ventricular systolic dysfunction, CHF), Hypersensitivity, Peripheral Sensory Neuropathy, Palmar-Plantar Erythrodysaesthesia Syndrome, Dyspepsia, Cough, Epistaxis, Oropharyngeal Pain, ALT Increased, Thrombocytopenia, Hypokalemia"
212,PERJETA,boxed warnings,"left ventricular dysfunction, CHF, decreased LVEF, subclinical cardiac failure, clinical cardiac failure, embryo-fetal death, birth defects, oligohydramnios, delayed renal development, death"
213,PERJETA,warnings and precautions,"Left Ventricular Dysfunction, LVEF declines, Symptomatic left ventricular systolic dysfunction, congestive heart failure, LVSD, Embryo-fetal toxicity, Fetal harm, oligohydramnios, delayed fetal kidney development, embryo-fetal death, Infusion-Related Reactions, hypersensitivity, anaphylactic reaction, acute infusion reaction, cytokine release syndrome, pyrexia, chills, fatigue, headache, asthenia, vomiting, dysgeusia, myalgia, Hypersensitivity Reactions, Anaphylaxis"
214,KEYTRUDA,adverse reactions,"immune-mediated pneumonitis, immune-mediated colitis, immune-mediated hepatitis, immune-mediated endocrinopathies, renal failure, immune-mediated nephritis, infusion-related reactions, fatigue, cough, nausea, pruritus, rash, decreased appetite, constipation, arthralgia, diarrhea, pain, serious adverse reactions, dyspnea, pneumonia, cellulitis, peripheral edema, chills, pyrexia, vomiting, abdominal pain, vitiligo, decreased appetite, pain in extremity, myalgia, back pain, headache, dizziness, anemia, insomnia, upper respiratory tract infection, sepsis, hyperglycemia, hyponatremia, hypoalbuminemia, hypertriglyceridemia, increased aspartate aminotransferase, hypocalcemia"
215,KEYTRUDA,warnings and precautions,"pneumonitis, moderate pneumonitis, severe pneumonitis, life-threatening pneumonitis, colitis, moderate colitis, severe colitis, life-threatening colitis, hepatitis, autoimmune hepatitis, Grade 4 hepatitis, hypophysitis, moderate hypophysitis, severe hypophysitis, life-threatening hypophysitis, hyperthyroidism, Grade 2 hyperthyroidism, Grade 3 hyperthyroidism, hypothyroidism, Grade 3 hypothyroidism, Type 1 diabetes mellitus, diabetic ketoacidosis, severe hyperglycemia, nephritis, Grade 2 autoimmune nephritis, interstitial nephritis, renal failure, Grade 3 renal failure, Grade 4 renal failure, exfoliative dermatitis, uveitis, arthritis, myositis, pancreatitis, hemolytic anemia, partial seizures, inflammatory foci in brain parenchyma, severe dermatitis, bullous pemphigoid, myasthenic syndrome, optic neuritis, rhabdomyolysis, infusion-related reactions, severe infusion-related reactions, life-threatening infusion-related reactions, embryofetal toxicity, fetal harm, death"
216,MYALEPT,adverse reactions,"headache, hypoglycemia, decreased weight, abdominal pain, arthralgia, dizziness, ear infection, fatigue, nausea, ovarian cyst, upper respiratory tract infection, anemia, back pain, diarrhea, paresthesia, proteinuria, pyrexia, injection-site erythema, urticaria, pancreatitis, severe infections, worsening of metabolic control (increases in HbA1c and/or triglycerides)"
217,MYALEPT,boxed warnings,"anti-metreleptin antibodies with neutralizing activity, inhibition of endogenous leptin action, loss of MYALEPT efficacy, severe infection, worsening metabolic control, T-cell lymphoma, death"
218,MYALEPT,warnings and precautions,"anti-metreleptin antibodies with neutralizing activity, loss of MYALEPT efficacy, severe infections, T-cell lymphoma, hypoglycemia, autoimmune disorder progression, hypersensitivity reactions, anaphylaxis, urticaria, generalized rash, Benzyl Alcohol Toxicity, death"
219,TRADJENTA,adverse reactions,"nasopharyngitis, hypoglycemia, diarrhea, cough, urinary tract infection, hypertriglyceridemia, hyperlipidemia, weight increased, constipation, back pain, arthralgia, upper respiratory tract infection, headache, pain in extremity, hypersensitivity, urticaria, angioedema, localized skin exfoliation, bronchial hyperreactivity, myalgia, pancreatitis, severe hypoglycemia, acute pancreatitis (including fatal pancreatitis, add 'death'), anaphylaxis, exfoliative skin conditions, severe and disabling arthralgia, rash, mouth ulceration, stomatitis"
220,TRADJENTA,warnings and precautions,"acute pancreatitis, fatal pancreatitis, death, hypoglycemia, anaphylaxis, angioedema, exfoliative skin conditions, severe and disabling arthralgia"
221,BRINTELLIX,adverse reactions,"Hypersensitivity, Clinical Worsening and Suicide Risk, Serotonin Syndrome, Abnormal Bleeding, Activation of Mania/Hypomania, Hyponatremia, Nausea, Constipation, Vomiting, Diarrhea, Dry mouth, Dizziness, Abnormal dreams, Pruritus, Sexual Dysfunction, Discontinuation symptoms (headache, muscle tension, mood swings, sudden outbursts of anger, dizziness, runny nose), Laboratory Tests abnormalities (Hyponatremia), Ear and labyrinth disorders (vertigo), Gastrointestinal disorders (dyspepsia), Nervous system disorders (dysgeusia), Vascular disorders (flushing)"
222,BRINTELLIX,boxed warnings,"suicidal thoughts, suicidal behaviors, worsening of depression, emergence of suicidal thoughts, emergence of suicidal behaviors"
223,BRINTELLIX,warnings and precautions,"Serotonin Syndrome, abnormal bleeding, Activation of Mania/Hypomania, Angle Closure Glaucoma, Hyponatremia, clinical worsening, suicide risk, suicidal ideation, suicidality, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, mania, mental status changes, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, gastrointestinal symptoms, nausea, vomiting, diarrhea, ecchymosis, hematoma, epistaxis, petechiae, hemorrhages, headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, seizure, coma, respiratory arrest, death."
224,AUBAGIO,adverse reactions,"Hepatotoxicity, Bone Marrow Effects, Immunosuppression Potential, Infections, Peripheral Neuropathy, Skin Reactions, Increased Blood Pressure, Respiratory Effects, headache, diarrhea, nausea, alopecia, increase in ALT, Paresthesia, Arthralgia, Neutropenia, Hypertension, Cardiovascular deaths (death), Acute Renal Failure, Hypophosphatemia"
225,AUBAGIO,boxed warnings,"hepatotoxicity, severe liver injury, fatal liver failure, death, major birth defects, teratogenicity"
226,AUBAGIO,warnings and precautions,"hepatotoxicity, fatal liver failure, liver dysfunction, elevated serum transaminases, ALT elevation, jaundice, serum transaminase increase, hepatic dysfunction, teratogenic effects, fetal death, decreased WBC count, neutropenia, lymphopenia, thrombocytopenia, pancytopenia, agranulocytosis, serious infection, klebsiella pneumonia sepsis, death, Pneumocystis jiroveci pneumonia, aspergillosis, cytomegalovirus hepatitis reactivation, tuberculosis, peripheral neuropathy, polyneuropathy, mononeuropathy, carpal tunnel syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, increased blood pressure, hypertension, interstitial lung disease, cough, dyspnea, hematologic toxicity."
227,POMALYST,adverse reactions,"fetal risk, venous and arterial thromboembolism, hematologic toxicity, hepatotoxicity, hypersensitivity reactions, dizziness, confusional state, neuropathy, second primary malignancies, tumor lysis syndrome, fatigue, asthenia, neutropenia, anemia, constipation, nausea, diarrhea, dyspnea, upper-respiratory tract infections, back pain, pyrexia, leukopenia, febrile neutropenia, lymphopenia, edema peripheral, chills, vomiting, musculoskeletal chest pain, muscle spasms, arthralgia, muscular weakness, bone pain, musculoskeletal pain, pain in extremity, pneumonia, urinary tract infection, sepsis, decreased appetite, hypercalcemia, hypokalemia, hyperglycemia, hyponatremia, dehydration, hypocalcemia, cough, epistaxis, productive cough, oropharyngeal pain, peripheral neuropathy, headache, tremor, rash, pruritus, dry skin, hyperhidrosis, night sweats, blood creatinine increased, weight decreased, weight increased, anxiety, insomnia, renal failure, neutrophil count decreased, platelet count decreased, white blood cell count decreased, alanine aminotransferase increased, aspartate aminotransferase increased, lymphocyte count decreased, myocardial infarction, atrial fibrillation, angina pectoris, cardiac failure congestive, vertigo, abdominal pain, general physical health deterioration, non-cardiac chest pain, multi-organ failure, hyperbilirubinemia, pneumocystis jiroveci pneumonia, respiratory syncytial virus infection, bacteremia, pneumonia respiratory syncytial viral, cellulitis, urosepsis, septic shock, clostridium difficile colitis, pneumonia streptococcal, lobar pneumonia, viral infection, lung infection, hemoglobin decreased, fall, compression fracture, spinal compression fracture, hyperkalemia, failure to thrive, depressed level of consciousness, syncope, mental status change, urinary retention, interstitial lung disease, pulmonary embolism, respiratory failure, bronchospasm, hypotension, pancytopenia, allergic reactions, angioedema, urticaria, elevated liver enzymes, hepatic failure, death"
228,POMALYST,boxed warnings,"embryo-fetal toxicity, severe birth defects, embryo-fetal death, deep venous thrombosis (DVT), pulmonary embolism (PE), myocardial infarction, stroke, death"
229,POMALYST,warnings and precautions,"neutropenia, hematologic toxicities, hepatotoxicity, hepatic failure, death, hypersensitivity reactions, angioedema, severe dermatologic reactions, tumor lysis syndrome, venous thromboembolic events, deep venous thrombosis, pulmonary embolism, arterial thromboembolic events, myocardial infarction, stroke, anemia, thrombocytopenia, febrile neutropenia, elevated levels of alanine aminotransferase, elevated bilirubin levels, skin exfoliation, bullae, dizziness, confusional state, neuropathy, peripheral neuropathy, acute myelogenous leukemia"
230,SURFAXIN,adverse reactions,"endotracheal tube reflux, pallor, endotracheal tube obstruction, need for dose interruption, oxygen desaturation, bradycardia, anemia, jaundice, metabolic acidosis, hyperglycemia, pneumonia, hyponatremia, hypotension, respiratory acidosis, death, multi-organ failure, sepsis, anoxic encephalopathy, renal failure, pneumothorax, pulmonary embolism"
231,SURFAXIN,warnings and precautions,"acute changes in lung compliance, bradycardia, oxygen desaturation, reflux of SURFAXIN into the endotracheal tube, airway/ETT obstruction, death, multi-organ failure, sepsis, anoxic encephalopathy, renal failure, hypoxia, pneumothorax, hypotension, pulmonary embolism"
232,ARZERRA,adverse reactions,"Infusion reactions, Hepatitis B Virus Reactivation, Hepatitis B Virus Infection, Progressive Multifocal Leukoencephalopathy, Tumor Lysis Syndrome, Cytopenias, Neutropenia, Pneumonia, Pyrexia, Cough, Diarrhea, Anemia, Fatigue, Dyspnea, Rash, Nausea, Bronchitis, Upper respiratory tract infections, Infections, Sepsis, Asthenia, Headache, Leukopenia, Herpes simplex, Lower respiratory tract infection, Arthralgia, Upper abdominal pain, Agranulocytosis, Edema peripheral, Back pain, Chills, Nasopharyngitis, Urticaria, Insomnia, Herpes zoster, Hyperhidrosis, Hypertension, Hypotension, Muscle spasms, Sinusitis, Tachycardia, Cardiac arrest, Stevens-Johnson syndrome, Porphyria cutanea tarda, death"
233,ARZERRA,boxed warnings,"Hepatitis B Virus Reactivation, fulminant hepatitis, hepatic failure, death, Progressive Multifocal Leukoencephalopathy (PML)"
234,ARZERRA,warnings and precautions,"infusion reactions, bronchospasm, dyspnea, laryngeal edema, pulmonary edema, flushing, hypertension, hypotension, syncope, cardiac events, myocardial ischemia/infarction, acute coronary syndrome, arrhythmia, bradycardia, back pain, abdominal pain, pyrexia, rash, urticaria, angioedema, cytokine release syndrome, anaphylactoid/anaphylactic reactions, death, Tumor Lysis Syndrome (TLS), Cytopenias, Neutropenia, anemia, thrombocytopenia, late-onset neutropenia, prolonged neutropenia, Hepatitis B Virus Reactivation, fulminant hepatitis, hepatic failure, Progressive Multifocal Leukoencephalopathy (PML), Pancytopenia, agranulocytosis, neutropenic sepsis"
235,ESBRIET,adverse reactions,"Liver Enzyme Elevations, Photosensitivity Reaction, Rash, Gastrointestinal Disorders, nausea, abdominal pain, upper respiratory tract infection, diarrhea, fatigue, headache, dyspepsia, dizziness, vomiting, anorexia, gastro-esophageal reflux disease, sinusitis, insomnia, weight decreased, arthralgia, decreased appetite, pruritus, asthenia, dysgeusia, non-cardiac chest pain, Agranulocytosis, Angioedema, Bilirubin increased"
236,ESBRIET,warnings and precautions,"elevated liver enzymes, ALT elevations, AST elevations, bilirubin elevations, photosensitivity, rash, gastrointestinal disorders, nausea, vomiting, diarrhea, dyspepsia, gastro-esophageal reflux disease, abdominal pain"
237,ACTEMRA,all-concat,"upper respiratory tract infections, nasopharyngitis, headache, hypertension, increased ALT, injection site reactions, serious infections, pneumonia, urinary tract infection, cellulitis, herpes zoster, gastroenteritis, diverticulitis, sepsis, bacterial arthritis, opportunistic infections, gastrointestinal perforations, infusion reactions, anaphylaxis, death, neutropenia, thrombocytopenia, elevated liver enzymes, lipids abnormalities, immunogenicity, malignancies, Stevens-Johnson Syndrome, tuberculosis, invasive fungal infections, viral reactivation, macrophage activation syndrome, demyelinating disorders, active hepatic disease, hepatic impairment, hypersensitivity reactions."
238,ADEMPAS,all-concat,"Embryo-Fetal Toxicity, Hypotension, Bleeding, Headache, Dyspepsia, Gastritis, Dizziness, Nausea, Diarrhea, Vomiting, Anemia, Gastroesophageal Reflux Disease, Constipation, Palpitations, Nasal Congestion, Epistaxis, Dysphagia, Abdominal Distension, Peripheral Edema, Symptomatic Hypotension, Pulmonary Edema, Serious Hemoptysis, Vaginal Hemorrhage, Catheter Site Hemorrhage, Subdural Hematoma, Hematemesis, Intra-Abdominal Hemorrhage, death (related to serious hemoptysis)"
239,AKYNZEO,all-concat,"headache, asthenia, dyspepsia, fatigue, constipation, erythema, hypersensitivity reactions, anaphylaxis, serotonin syndrome, mental status changes, autonomic instability, neuromuscular symptoms, seizures, gastrointestinal symptoms"
240,ANORO,all-concat,"asthma-related death, paradoxical bronchospasm, cardiovascular effects, worsening of narrow-angle glaucoma, worsening of urinary retention, pharyngitis, sinusitis, lower respiratory tract infection, constipation, diarrhea, pain in extremity, muscle spasms, neck pain, chest pain, productive cough, dry mouth, dyspepsia, abdominal pain, gastroesophageal reflux disease, vomiting, musculoskeletal chest pain, chest discomfort, asthenia, atrial fibrillation, ventricular extrasystoles, supraventricular extrasystoles, myocardial infarction, pruritus, rash, conjunctivitis, headache, back pain, cough, urinary tract infection, arthralgia, nausea, vertigo, pleuritic pain, viral respiratory tract infection, toothache, diabetes mellitus, death"
241,ARCALYST,all-concat,"Mycobacterium intracellulare infection, gastrointestinal bleeding, colitis, sinusitis, bronchitis, Streptococcus pneumoniae meningitis, death, injection-site reaction (ISR), upper respiratory infection, neutropenia, hypersensitivity reactions, lipid profile changes"
242,ARZERRA,all-concat,"infusion reactions, hepatitis B virus reactivation, hepatitis B virus infection, progressive multifocal leukoencephalopathy, tumor lysis syndrome, cytopenias, neutropenia, pneumonia, pyrexia, cough, diarrhea, anemia, fatigue, dyspnea, rash, nausea, bronchitis, upper respiratory tract infections, asthenia, headache, leukopenia, herpes simplex, lower respiratory tract infection, arthralgia, upper abdominal pain, lymphopenia, edema peripheral, back pain, chills, nasopharyngitis, sepsis, urticaria, insomnia, herpes zoster, hyperhidrosis, hypertension, hypotension, muscle spasms, sinusitis, tachycardia, cardiac arrest, Stevens-Johnson syndrome, porphyria cutanea tarda, death"
243,ASCLERA,all-concat,"mild local reactions at the site of injection, injection site haematoma, injection site irritation, injection site discoloration, injection site pain, injection site pruritus, injection site warmth, neovascularisation, injection site thrombosis, anaphylactic shock, angioedema, urticaria generalized, asthma, cerebrovascular accident, migraine, paresthesia (local), loss of consciousness, confusional state, dizziness, cardiac arrest, palpitations, deep vein thrombosis, pulmonary embolism, syncope vasovagal, circulatory collapse, vasculitis, dyspnea, skin hyperpigmentation, dermatitis allergic, hypertrichosis, injection site necrosis, pyrexia, hot flush, nerve injury, tissue necrosis, anaphylaxis, severe necrosis, ischemia, gangrene, severe pain, death"
244,AUBAGIO,all-concat,"Hepatotoxicity, Bone Marrow Effects, Immunosuppression Potential, Infections, Peripheral Neuropathy, Skin Reactions, Increased Blood Pressure, Respiratory Effects, Acute Renal Failure, Hypophosphatemia, death"
245,BANZEL,all-concat,"Suicidal Behavior and Ideation, Central Nervous System Reactions, QT Shortening, Multi-Organ Hypersensitivity/Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Leukopenia, headache, dizziness, fatigue, somnolence, nausea, vomiting, decreased appetite, rash, ataxia, diplopia, bronchitis, sinusitis, psychomotor hyperactivity, upper abdominal pain, aggression, ear infection, disturbance in attention, pruritis, tremor, nystagmus, blurred vision, anxiety, constipation, dyspepsia, back pain, gait disturbance, vertigo, convulsion, Stevens-Johnson syndrome, anemia, lymphadenopathy, neutropenia, iron deficiency anemia, thrombocytopenia, bundle branch block right, atrioventricular block first degree, increased appetite, pollakiuria, urinary incontinence, dysuria, hematuria, nephrolithiasis, polyuria, enuresis, nocturia, incontinence, pneumonia, decreased weight, gastroenteritis, nasal congestion, pneumonia aspiration."
246,BELSOMRA,all-concat,"CNS depressant effects, daytime impairment, abnormal thinking, behavioral changes, worsening of depression, suicidal ideation, sleep paralysis, hypnagogic/hypnopompic hallucinations, cataplexy-like symptoms, somnolence, diarrhea, dry mouth, upper respiratory tract infection, headache, dizziness, abnormal dreams, cough, daytime somnolence, impaired alertness, motor coordination impairment, sleep-driving, compromised respiratory function"
247,BELVIQ,all-concat,"Serotonin Syndrome, NMS-like Reactions, Valvular Heart Disease, Cognitive Impairment, Psychiatric Disorders, Hypoglycemia, Heart Rate Decreases, Hematological Changes, Prolactin Elevation, Eye disorders, Euphoria, Depression, Suicidality, Lymphocyte and Neutrophil Counts, Hemoglobin, Priapism, Pulmonary Hypertension"
248,BRILINTA,all-concat,"bleeding, dyspnea, death, intracranial hemorrhage, major bleeding, fatal/life-threatening bleeding, non-CABG major bleeding, CABG-related bleeding, dizziness, nausea, bradycardia, syncope, pre-syncope, loss of consciousness, gout, serum uric acid increased, serum creatinine increased, renal failure, acute renal failure, chronic renal failure, toxic nephropathy, oliguria"
249,BRINTELLIX,all-concat,"Hypersensitivity, Clinical Worsening, Suicide Risk, Serotonin Syndrome, Abnormal Bleeding, Activation of Mania/Hypomania, Hyponatremia, Nausea, Constipation, Vomiting, Diarrhea, Dry mouth, Flatulence, Dizziness, Abnormal dreams, Pruritus, Sexual Dysfunction, Headache, Muscle tension, Mood swings, Sudden outbursts of anger, Runny nose, Vertigo, Dyspepsia, Dysgeusia, Flushing, Suicidal thoughts and behaviors, Agitation, Hallucinations, Delirium, Coma, Autonomic instability, Tachycardia, Labile blood pressure, Diaphoresis, Hyperthermia, Neuromuscular symptoms, Tremor, Rigidity, Myoclonus, Hyperreflexia, Incoordination, Seizures, Gastrointestinal symptoms, Difficulty concentrating, Memory impairment, Confusion, Weakness, Unsteadiness, Hallucination, Syncope, Seizure, Coma, Respiratory arrest, Death"
250,CAPRELSA,all-concat,"QT Prolongation, Torsades de Pointes, sudden death, Skin Reactions, Stevens-Johnson Syndrome, Interstitial Lung Disease, Ischemic Cerebrovascular Events, Hemorrhage, Heart Failure, Diarrhea, Hypothyroidism, Hypertension, Reversible Posterior Leukoencephalopathy Syndrome, Embryofetal Toxicity, intestinal perforation, Grade 1-2 bleeding events, Hypocalcemia, ALT Increased, Hypoglycemia, Creatinine Increased, Hypomagnesemia, Neutropenia, Thrombocytopenia, Corneal Abnormalities, Blurred Vision, Proteinuria, Depression, Muscle Spasms, pancreatitis, photosensitivity reactions, severe skin reactions, pneumonitis, severe ischemic cerebrovascular event, severe hemorrhage, hypertensive crisis, seizures, headache, visual disturbances, confusion, altered mental function, renal impairment, hepatic impairment, embryotoxicity, fetotoxicity, teratogenicity, adverse effects on female fertility, embryofetal development, postnatal development of pups."
251,CYRAMZA,all-concat,"hemorrhage, gastrointestinal hemorrhage, arterial thromboembolic events, myocardial infarction, cardiac arrest, cerebrovascular accident, cerebral ischemia, hypertension, infusion-related reactions, impaired wound healing, clinical deterioration in patients with Child-Pugh B or C cirrhosis, reversible posterior leukoencephalopathy syndrome, proteinuria, nephrotic syndrome, thyroid dysfunction, embryofetal toxicity, death"
252,DALIRESP,all-concat,"Psychiatric Events Including Suicidality, Weight Decrease, Diarrhea, Nausea, Headache, Back Pain, Influenza, Insomnia, Dizziness, Decreased Appetite, Abdominal Pain, Dyspepsia, Gastritis, Vomiting, Rhinitis, Sinusitis, Urinary Tract Infection, Muscle Spasms, Tremor, Anxiety, Depression, Hypersensitivity Reactions Including Angioedema, Urticaria, Rash, Atrial Fibrillation, Lung Cancer, Prostate Cancer, Acute Pancreatitis, Acute Renal Failure, Suicidal Ideation, Suicide Attempts, Completed Suicide, Moderate Weight Loss, Severe Weight Loss, Acute Bronchospasm (as a warning not to use for relief of acute bronchospasm)."
253,EDURANT,all-concat,"Skin and Hypersensitivity Reactions, Depressive Disorders, Hepatotoxicity, headache, insomnia, rash, abdominal pain, fatigue, dizziness, abnormal dreams, diarrhea, abdominal discomfort, cholecystitis, cholelithiasis, decreased appetite, somnolence, sleep disorders, anxiety, glomerulonephritis membranous, glomerulonephritis mesangioproliferative, nephrolithiasis, increased creatinine, increased AST, increased ALT, increased total bilirubin, increased total cholesterol, increased LDL cholesterol, increased triglycerides, adrenal insufficiency, nephrotic syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), redistribution/accumulation of body fat, immune reconstitution syndrome, death"
254,EFFIENT,all-concat,"Bleeding, life-threatening bleeding, fatal bleeding, death, Thrombotic thrombocytopenic purpura, Symptomatic intracranial hemorrhage, Requiring inotropes, Requiring surgical intervention, Requiring transfusion (>=4 units), Hemorrhagic events, epistaxis, gastrointestinal hemorrhage, hemoptysis, subcutaneous hematoma, post-procedural hemorrhage, retroperitoneal hemorrhage, pericardial effusion/hemorrhage/tamponade, retinal hemorrhage, severe thrombocytopenia, anemia, abnormal hepatic function, allergic reactions, angioedema, Thrombocytopenia, Hypersensitivity reactions, anaphylaxis"
255,EGRIFTA,all-concat,"hypersensitivity reactions, rash, urticaria, arthralgia, extremity pain, peripheral edema, hyperglycemia, carpal tunnel syndrome, injection site reactions, injection site erythema, pruritus, pain, irritation, swelling, hemorrhage, myalgia, musculoskeletal pain, musculoskeletal stiffness, joint stiffness, muscle spasms, joint swelling, chest pain, injection site rash, paresthesia, hypoesthesia, nausea, vomiting, dyspepsia, abdominal pain upper, palpitations, depression, night sweats, hypertension, muscle strain, blood creatine phosphokinase increased, diabetes, neuropathy peripheral, insomnia, hot flush, fluid retention, glucose intolerance, injection site bruising, acute critical illness"
256,ELELYSO,all-concat,"pruritus, flushing, headache, arthralgia, pain in extremity, abdominal pain, vomiting, fatigue, back pain, dizziness, nausea, rash, urticaria, hypersensitivity reactions, severe vomiting, gastrointestinal inflammation, throat irritation, chest discomfort, anaphylaxis, angioedema, erythema, cough, chest tightness, throat irritation, hypotension, wheezing, Type III immune-mediated fixed drug eruption, death"
257,ELLA,all-concat,"headache, abdominal pain, nausea, dysmenorrhea, fatigue, dizziness, acne, ectopic pregnancy, alteration of menstrual cycle, intermenstrual bleeding"
258,ENTYVIO,all-concat,"Infusion-Related Reactions, Hypersensitivity Reactions, anaphylaxis, dyspnea, bronchospasm, urticaria, flushing, rash, increased blood pressure, increased heart rate, Infections, Progressive Multifocal Leukoencephalopathy, Liver Injury, hepatitis, elevated transaminases, elevated bilirubin, jaundice, Malignancies, colon cancer, transitional cell carcinoma, breast cancer, carcinoid tumor, squamous cell carcinoma, B-cell lymphoma, malignant hepatic neoplasm, malignant lung neoplasm, malignant melanoma, primary neuroendocrine carcinoma, renal cancer, sepsis, bacterial sepsis, septic shock, tuberculosis, salmonella sepsis, Listeria meningitis, giardiasis, cytomegaloviral colitis, death"
259,ERIVEDGE,all-concat,"muscle spasms, alopecia, dysgeusia, weight loss, fatigue, nausea, diarrhea, decreased appetite, constipation, arthralgias, vomiting, ageusia, amenorrhea, hyponatremia, hypokalemia, azotemia, embryo-fetal death, severe birth defects, embryotoxicity, fetotoxicity, teratogenic effects"
260,ESBRIET,all-concat,"Liver Enzyme Elevations, Photosensitivity Reaction, Rash, Gastrointestinal Disorders, Nausea, Abdominal Pain, Upper Respiratory Tract Infection, Diarrhea, Fatigue, Headache, Dyspepsia, Dizziness, Vomiting, Anorexia, Gastro-esophageal Reflux Disease, Sinusitis, Insomnia, Weight Decreased, Arthralgia, Photosensitivity Reaction, Decreased Appetite, Pruritus, Asthenia, Dysgeusia, Non-cardiac Chest Pain, Agranulocytosis, Angioedema, Bilirubin Increased, ALT and AST Elevations"
261,FOLOTYN,all-concat,"Bone Marrow Suppression, Mucositis, Dermatologic Reactions, Tumor Lysis Syndrome, Hepatic Toxicity, Thrombocytopenia, Nausea, Fatigue, Pyrexia, Sepsis, Febrile Neutropenia, Dehydration, Dyspnea, Anemia, Constipation, Edema, Cough, Epistaxis, Vomiting, Neutropenia, Diarrhea, Anorexia, Hypokalemia, Rash, Pruritus, Pharyngolaryngeal pain, Liver function test abnormal, Abdominal pain, Pain in extremity, Back pain, Leukopenia, Night sweats, Asthenia, Tachycardia, Upper respiratory tract infection, Cardiopulmonary arrest, Toxic epidermal necrolysis, death"
262,FYCOMPA,all-concat,"Serious Psychiatric and Behavioral Reactions, Suicidal Behavior and Ideation, Dizziness, Gait Disturbance, Somnolence, Fatigue, Falls, Nausea, Weight Gain, Vertigo, Ataxia, Headache, Vomiting, Contusion, Abdominal Pain, Anxiety, Aggression, Anger, Blurred Vision, Irritability, Dysarthria, Back Pain, Hypersomnia, Balance Disorder, Diplopia, Head Injury, Hypoaesthesia, Pain in Extremity, Constipation, Myalgia, Coordination Abnormal, Euphoric Mood, Confusional State, Hyponatremia, Limb Injury, Mood Altered, Arthralgia, Asthenia, Memory Impairment, Musculoskeletal Pain, Oropharyngeal Pain, Paraesthesia, Peripheral Edema, Skin Laceration, Urinary Tract Infection, Ligament Sprain, Rash, Elevated Triglycerides, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Hostility, Belligerence, Affect Lability, Agitation, Physical Assault, Homicidal Ideation and Threats, Paranoia, Mental Status Changes, Disorientation, Confusional State, Delusion, Depression, Suicidal Thoughts, Behavior Changes, Suicidal Behavior, Lethargy, Bone Fracture, Death"
263,GATTEX,all-concat,"abdominal pain, injection site reactions, nausea, headaches, abdominal distension, upper respiratory tract infection, vomiting, fluid overload, flatulence, hypersensitivity, appetite disorders, sleep disturbances, cough, skin hemorrhage, gastrointestinal stoma complication, malignancy, colorectal polyps, gastrointestinal obstruction, gallbladder disease, biliary disease, pancreatic disease, congestive heart failure, altered mental status"
264,GAZYVA,all-concat,"Hepatitis B reactivation, Progressive multifocal leukoencephalopathy, Infusion reactions, Tumor lysis syndrome, Infections, Neutropenia, Thrombocytopenia, Anemia, Pyrexia, Cough, Nausea, Diarrhea, Urinary tract infection, Back pain, Nasopharyngitis, Constipation, Lymphopenia, Leukopenia, Hypocalcemia, Hyperkalemia, Hyponatremia, AST (SGOT increased), Creatinine increased, ALT (SGPT increased), Hypoalbuminemia, Alkaline phosphatase increased, Hypokalemia, Hemorrhagic events, Musculoskeletal disorders, Liver enzyme elevations, Worsening of pre-existing cardiac conditions, death"
265,HARVONI,all-concat,"fatigue, headache, nausea, diarrhea, insomnia, bilirubin elevations, lipase elevations, serious symptomatic bradycardia, cardiac arrest, death"
266,HETLIOZ,all-concat,"headache, increased alanine aminotransferase, nightmares, unusual dreams, upper respiratory tract infection, urinary tract infection, somnolence"
267,ICLUSIG,all-concat,"vascular occlusion, heart failure, hepatotoxicity, hypertension, pancreatitis, neuropathy, ocular toxicity, hemorrhage, fluid retention, cardiac arrhythmias, myelosuppression, tumor lysis syndrome, compromised wound healing, gastrointestinal perforation, embryo-fetal toxicity, arterial ischemia, cardiac failure, peripheral neuropathy, arterial occlusive events, myocardial infarction, stroke, peripheral vascular disease, venous thromboembolism, deep venous thrombosis, pulmonary embolism, superficial thrombophlebitis, retinal vein thrombosis, heart failure, left ventricular dysfunction, liver failure, death, serious bleeding events, cerebral hemorrhage, gastrointestinal hemorrhage, serious fluid retention, brain edema, pericardial effusion, pleural effusion, ascites, symptomatic bradyarrhythmias, supraventricular tachyarrhythmias, atrial fibrillation, atrial flutter, supraventricular tachycardia, atrial tachycardia, severe myelosuppression, serious tumor lysis syndrome, gastrointestinal perforation (fistula)"
268,IMPAVIDO,all-concat,"nausea, vomiting, diarrhea, headache, decreased appetite, dizziness, abdominal pain, pruritus, somnolence, elevated transaminases, elevated creatinine, death, Stevens-Johnson syndrome, melena, thrombocytopenia, arthritis, skin rash, CTCAE Grade 4 diarrhea, CTCAE Grade 4 hyperbilirubinemia, asthenia, motion sickness, malaise, pyrexia, lymphangitis, agranulocytosis, generalized edema, peripheral edema, jaundice, seizure, scrotal pain, decreased ejaculate volume, absent ejaculation, epistaxis, embryo-fetal toxicity, fetal death, teratogenicity, reproductive effects, testicular atrophy, impaired fertility, renal effects, hepatic effects, gastrointestinal effects, thrombocytopenia, absorption of oral contraceptives"
269,ISTODAX,all-concat,"myelosuppression, infection, electrocardiographic changes, tumor lysis syndrome, neutropenia, lymphopenia, thrombocytopenia, nausea, fatigue, vomiting, anorexia, anemia, ECG T-wave changes, asthenia, hypomagnesemia, diarrhea, pyrexia, dysgeusia, constipation, hypotension, pruritus, hypokalemia, dermatitis, exfoliative dermatitis, hypocalcemia, leukopenia, alanine aminotransferase increased, aspartate aminotransferase increased, hypoalbuminemia, electrocardiogram ST-T wave changes, hyperglycemia, hyponatremia, hypermagnesemia, hypophosphatemia, hyperuricemia, sepsis, supraventricular arrhythmia, central line infection, edema, ventricular arrhythmia, dehydration, dyspnea, reactivation of hepatitis B virus infection, cardiopulmonary failure, acute renal failure, myocardial ischemia, acute respiratory distress syndrome, QT prolongation, gastrointestinal disorders, abdominal pain, stomatitis, general disorders, administration site conditions, chills, edema peripheral, blood and lymphatic system disorders, metabolism and nutrition disorders, nervous system disorders, headache, respiratory, thoracic and mediastinal disorders, cough, investigations, weight decreased, cardiac disorders, tachycardia, pneumonia, cellulitis, deep vein thrombosis, febrile neutropenia, chest pain, pulmonary embolism, multi-organ failure, septic shock, candida sepsis, sepsis/cardiogenic shock, Epstein Barr virus reactivation, hypersensitivity, pneumonitis, packed red blood cell transfusion, platelet transfusion, death."
270,JAKAFI,all-concat,"thrombocytopenia, anemia, neutropenia, risk of infection, symptom exacerbation following interruption or discontinuation of treatment, non-melanoma skin cancer, bruising, dizziness, headache, urinary tract infections, weight gain, flatulence, herpes zoster, alanine transaminase (ALT) elevations, aspartate transaminase (AST) elevations, cholesterol elevations, abdominal pain, diarrhea, fatigue, pruritus, dyspnea, muscle spasms, nasopharyngitis, constipation, cough, edema, arthralgia, asthenia, epistaxis, nausea, hypercholesterolemia, hypertriglyceridemia, hypertension"
271,JETREA,all-concat,"Decreased Vision, Intravitreal Injection Procedure Associated Effects, Potential for Lens Subluxation, Retinal Breaks, vitreous floaters, conjunctival hemorrhage, eye pain, photopsia, blurred vision, macular hole, reduced visual acuity, visual impairment, retinal edema, macular edema, increased intraocular pressure, anterior chamber cell, photophobia, vitreous detachment, ocular discomfort, iritis, cataract, dry eye, metamorphopsia, conjunctival hyperemia, retinal degeneration, Dyschromatopsia, intraocular inflammation, intraocular hemorrhage, lens subluxation, retinal detachment, retinal tear, yellowish vision, electroretinographic changes, a-wave amplitude decrease, b-wave amplitude decrease"
272,JUXTAPID,all-concat,"hepatotoxicity, reduced absorption of fat-soluble vitamins, serum fatty acids, gastrointestinal adverse reactions, diarrhea, nausea, vomiting, dyspepsia, abdominal pain, abdominal discomfort, abdominal distension, constipation, flatulence, increased ALT, chest pain, influenza, nasopharyngitis, fatigue, weight loss, gastroenteritis, headache, difficulty controlling INR on warfarin, increased AST, hepatic steatosis, steatohepatitis, cirrhosis, embryo-fetal toxicity, malabsorption, myopathy, rhabdomyolysis, supratherapeutic anticoagulation, subtherapeutic anticoagulation, galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption"
273,KADCYLA,all-concat,"hepatotoxicity, liver failure, death, left ventricular dysfunction, embryo-fetal toxicity, pulmonary toxicity, infusion-related reactions, hypersensitivity reactions, hemorrhage, thrombocytopenia, neurotoxicity, hepatobiliary disorders, nodular regenerative hyperplasia, portal hypertension, cardiac disorders, eye disorders, gastrointestinal disorders, general disorders and administration site conditions, immune system disorders, injury, poisoning and procedural complications, infections and infestations, metabolism and nutrition disorders, musculoskeletal and connective tissue disorders, nervous system disorders, psychiatric disorders, respiratory, thoracic and mediastinal disorders, skin and subcutaneous tissue disorders, vascular disorders, increased bilirubin, increased AST, increased ALT, decreased platelet count, decreased hemoglobin, decreased neutrophils, decreased potassium, interstitial lung disease, pneumonitis, acute respiratory distress syndrome, anemia, hypokalemia, peripheral neuropathy, fatigue, neutropenia, leukopenia, pyrexia, hepatobiliary disorders, drug hypersensitivity, infusion-related reaction, urinary tract infection, blood alkaline phosphatase increased, hypokalemia, myalgia, arthralgia, musculoskeletal pain, dysgeusia, dizziness, peripheral neuropathy, headache, insomnia, pneumonitis, dyspnea, cough, epistaxis, pruritus, rash, hemorrhage, hypertension, extravasation"
274,KERYDIN,all-concat,"application site exfoliation, ingrown toenail, application site erythema, application site dermatitis"
275,KEYTRUDA,all-concat,"immune-mediated pneumonitis, immune-mediated colitis, immune-mediated hepatitis, immune-mediated endocrinopathies, renal failure, immune-mediated nephritis, infusion-related reactions, fatigue, cough, nausea, pruritus, rash, decreased appetite, constipation, arthralgia, diarrhea, peripheral edema, chills, pyrexia, vomiting, abdominal pain, dyspnea, pneumonia, cellulitis, vitiligo, decreased appetite, pain in extremity, myalgia, back pain, headache, dizziness, anemia, insomnia, upper respiratory tract infection, sepsis, hyperglycemia, hyponatremia, hypoalbuminemia, hypertriglyceridemia, increased aspartate aminotransferase, hypocalcemia, hypophysitis, thyroid disorders, hyperthyroidism, hypothyroidism, type 1 diabetes mellitus, exfoliative dermatitis, uveitis, arthritis, myositis, pancreatitis, hemolytic anemia, partial seizures, bullous pemphigoid, myasthenic syndrome, optic neuritis, rhabdomyolysis, embryofetal toxicity"
276,KIT,all-concat,"injection site irritation, injection site pain, hypersensitivity reactions, serious hypersensitivity reactions, increased risk for cancer, excessive radiation exposure, death"
277,KRYSTEXXA,all-concat,"anaphylaxis, infusion reactions, gout flares, nausea, contusion, ecchymosis, nasopharyngitis, constipation, chest pain, vomiting, congestive heart failure exacerbation, urticaria, dyspnea, erythema, pruritus, wheezing, peri-oral edema, lingual edema, hemodynamic instability, rash, delayed-type hypersensitivity reactions"
278,KYNAMRO,all-concat,"hepatotoxicity, injection site reactions, flu-like symptoms, nausea, headache, elevations in serum transaminases, ALT increased, flu-like symptoms, aspartate aminotransferase increased, liver function test abnormal, angina pectoris, palpitations, vomiting, abdominal pain, fatigue, influenza like illness, pyrexia, chills, edema peripheral, hepatic steatosis, alanine aminotransferase increased, aspartate aminotransferase increased, liver function test abnormal, hepatic enzyme increased, pain in extremity, musculoskeletal pain, insomnia, hypertension, proteinuria, hypersensitivity reaction, angioedema, glomerular nephritis, thrombocytopenia, idiopathic thrombocytopenic purpura, erythema, pain, hematoma, pruritus, swelling, discoloration, myalgia, arthralgia, malaise, immunogenicity, anti-KYNAMRO antibodies, hepatotoxicity, steatohepatitis, cirrhosis, nausea, vomiting, abdominal pain, fever, jaundice, lethargy, alcohol-induced liver injury, hepatotoxic medications interaction, REMS"
279,LASTACAFT,all-concat,"eye irritation, burning and/or stinging on instillation, eye redness, eye pruritus, nasopharyngitis, headache, eye discharge, eye swelling, erythema of eyelid, eyelid edema, hypersensitivity, somnolence"
280,LATUDA,all-concat,"Increased Mortality in Elderly Patients with Dementia-Related Psychosis, Suicidal Thoughts and Behaviors, Cerebrovascular Adverse Reactions (including stroke, transient ischemic attack), Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes (Hyperglycemia, Diabetes Mellitus, Dyslipidemia, Weight Gain), Hyperprolactinemia, Leukopenia, Neutropenia, Agranulocytosis, Orthostatic Hypotension, Syncope, Seizures, Potential for Cognitive and Motor Impairment, Body Temperature Dysregulation, Suicide, Activation of Mania/Hypomania, Dysphagia, Neurological Adverse Reactions in Patients with Parkinson's Disease or Dementia with Lewy Bodies, death"
281,LEXISCAN,all-concat,"Myocardial Ischemia, Sinoatrial Nodal Block, Atrioventricular Nodal Block, Atrial Fibrillation, Atrial Flutter, Hypersensitivity, Anaphylaxis, Hypotension, Hypertension, Bronchoconstriction, Seizure, Cerebrovascular Accident, Stroke, Myocardial Infarction, Cardiac Arrest, Ventricular Arrhythmias, Supraventricular Tachyarrhythmias, Heart Block, Asystole, Transient Ischemic Attack, Syncope, QTc Prolongation, Tremor, Transient Ischemic Attack, Intracranial Hemorrhage, Abdominal Pain, Diarrhea, Fecal Incontinence, Angioedema, Respiratory Arrest, Respiratory Distress, Decreased Oxygen Saturation, Throat Tightness, Urticaria, Rashes, Musculoskeletal Pain, Dyspnea, Wheezing, Renal Impairment, death"
282,LINZESS,all-concat,"diarrhea, abdominal pain, flatulence, abdominal distension, viral gastroenteritis, headache, fecal incontinence, dehydration, gastroesophageal reflux disease, vomiting, fatigue, dyspepsia, upper respiratory tract infection, sinusitis, rectal hemorrhage, hematochezia, melena, allergic reactions, urticaria, hives, death"
283,LIVALO,all-concat,"rhabdomyolysis, myoglobinuria, acute renal failure, myopathy, myositis, liver enzyme abnormalities, myalgia, back pain, diarrhea, constipation, pain in extremity, arthralgia, headache, influenza, nasopharyngitis, elevated creatine phosphokinase, transaminases, alkaline phosphatase, bilirubin, glucose, hypersensitivity reactions, rash, pruritus, urticaria, abdominal discomfort, abdominal pain, dyspepsia, nausea, asthenia, fatigue, malaise, hepatitis, jaundice, hepatic failure, dizziness, hypoesthesia, insomnia, depression, interstitial lung disease, erectile dysfunction, muscle spasms, cognitive impairment, memory loss, forgetfulness, amnesia, memory impairment, confusion, immune-mediated necrotizing myopathy (IMNM), elevated serum creatine kinase, increases in HbA1c, fasting serum glucose levels, death"
284,LUMASON,all-concat,"severe cardiopulmonary reactions, hypersensitivity reactions, headache, nausea, hypersensitivity-type rash, near syncope symptoms, anaphylactic shock, dysgeusia, injection site pain, chest discomfort, feeling hot, chest pain, injection site warmth, fatalities, arrhythmias, hypertensive episodes, fatal cardiac or respiratory arrest, shock, syncope, symptomatic arrhythmias, atrial fibrillation, tachycardia, bradycardia, supraventricular tachycardia, ventricular fibrillation, ventricular tachycardia, hypertension, hypotension, dyspnea, hypoxia, respiratory distress, stridor, wheezing, loss of consciousness, convulsions, skin erythema, rash, urticaria, flushing, throat tightness, systemic embolization, tissue ischemia, ventricular arrhythmias, death"
285,LUZU,all-concat,"application site reactions, contact dermatitis, cellulitis"
286,LYNPARZA,all-concat,"Myelodysplastic syndrome, Acute Myeloid Leukemia, Pneumonitis, Anemia, Nausea, Fatigue, Asthenia, Vomiting, Diarrhea, Dysgeusia, Dyspepsia, Headache, Decreased appetite, Nasopharyngitis, Pharyngitis, Upper Respiratory Infection, URI, Cough, Arthralgia, Musculoskeletal pain, Myalgia, Back pain, Dermatitis, Rash, Abdominal pain, Discomfort, Increase in creatinine, Mean corpuscular volume elevation, Decrease in hemoglobin, Decrease in lymphocytes, Decrease in absolute neutrophil count, Decrease in platelets, Death, COPD, Cerebrovascular accident, Intestinal perforation, Pulmonary embolism, Sepsis, Suture rupture, Constipation, Peripheral edema, Dizziness, Urinary tract infection, Dyspnea, Leukopenia, Stomatitis, Peripheral neuropathy, Pyrexia, Hypomagnesemia, Hyperglycemia, Anxiety, Depression, Insomnia, Dysuria, Urinary incontinence, Vulvovaginal disorder, Dry skin, Eczema, Pruritis, Hypertension, Venous thrombosis, Hot flush, Lethargy, Embryo-Fetal toxicity."
287,MEKINIST,all-concat,"New Primary Malignancies, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Interstitial Lung Disease, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, death"
288,MOVANTIK,all-concat,"Gastrointestinal perforation, Opioid withdrawal, Abdominal pain, Diarrhea, Nausea, Flatulence, Vomiting, Headache, Hyperhidrosis, Chills, Anxiety, Irritability, Yawning"
289,MYALEPT,all-concat,"headache, hypoglycemia, decreased weight, abdominal pain, arthralgia, dizziness, ear infection, fatigue, nausea, ovarian cyst, upper respiratory tract infection, anemia, back pain, diarrhea, paresthesia, proteinuria, pyrexia, injection-site erythema, urticaria, pancreatitis, severe infections, worsening metabolic control, increases in HbA1c, increases in triglycerides, excessive weight gain, development of glucose intolerance, diabetes mellitus, autoimmune disorder progression, hypersensitivity reactions, anaphylaxis, generalized rash, benzyl alcohol toxicity, T-cell lymphoma, death"
290,MYRBETRIQ,all-concat,"hypertension, nasopharyngitis, urinary tract infection, headache, nausea, diarrhea, constipation, dizziness, tachycardia, atrial fibrillation, prostate cancer, upper respiratory tract infection, arthralgia, abdominal pain, fatigue, palpitations, blood pressure increased, glaucoma, dyspepsia, gastritis, abdominal distension, sinusitis, rhinitis, GGT increased, AST increased, ALT increased, LDH increased, nephrolithiasis, bladder pain, vulvovaginal pruritus, vaginal infection, urticaria, leukocytoclastic vasculitis, rash, pruritus, purpura, lip edema, back pain, dry mouth, cerebrovascular accident, osteoarthritis, neoplasm, breast cancer, lung neoplasm malignant, Stevens-Johnson syndrome, angioedema, urinary retention, dry eyes, vision blurred, death"
291,NATROBA,all-concat,"application site erythema, ocular erythema, application site irritation, application site dryness, application site exfoliation, alopecia, dry skin, benzyl alcohol toxicity, death"
292,NPLATE,all-concat,"arthralgia, dizziness, insomnia, myalgia, pain in extremity, abdominal pain, shoulder pain, dyspepsia, paresthesia, headache, bone marrow reticulin deposition, worsening thrombocytopenia after Nplate discontinuation, erythromelalgia, hypersensitivity, angioedema, progression of myelodysplastic syndromes to acute myelogenous leukemia (death), thrombotic/thromboembolic complications, portal vein thrombosis, bone marrow fibrosis, worsened thrombocytopenia after cessation of Nplate"
293,NUCYNTA,all-concat,"Respiratory Depression, Interaction with Alcohol, Chronic Pulmonary Disease, Hypotensive Effects, Interactions with Other CNS Depressants, Drug abuse, addiction, and dependence, Gastrointestinal Effects, Seizures, Serotonin Syndrome, nausea, dizziness, vomiting, somnolence, headache, constipation, dry mouth, dyspepsia, fatigue, feeling hot, nasopharyngitis, upper respiratory tract infection, urinary tract infection, decreased appetite, tremor, lethargy, insomnia, confusional state, abnormal dreams, anxiety, pruritus, hyperhidrosis, pruritus generalized, rash, hot flush, heart rate increased, heart rate decreased, visual disturbance, abdominal discomfort, impaired gastric emptying, irritability, edema, drug withdrawal syndrome, feeling drunk, hypersensitivity, gamma-glutamyltransferase increased, alanine aminotransferase increased, aspartate aminotransferase increased, involuntary muscle contractions, sensation of heaviness, hypoesthesia, paresthesia, disturbance in attention, sedation, dysarthria, depressed level of consciousness, memory impairment, ataxia, presyncope, syncope, coordination abnormal, euphoric mood, disorientation, restlessness, agitation, nervousness, thinking abnormal, urinary hesitation, pollakiuria, oxygen saturation decreased, cough, dyspnea, respiratory depression, urticaria, blood pressure decreased, diarrhea, headache, hallucination, suicidal ideation, panic attack, palpitations, anaphylaxis, angioedema, anaphylactic shock, death"
294,OFEV,all-concat,"Liver Enzyme and Bilirubin Elevations, Gastrointestinal Disorders, Embryofetal Toxicity, Arterial Thromboembolic Events, Risk of Bleeding, Gastrointestinal Perforation, diarrhea, nausea, abdominal pain, vomiting, liver enzyme elevation, decreased appetite, headache, weight decreased, hypertension, bronchitis, myocardial infarction, pneumonia, lung neoplasm malignant, hypothyroidism, ALT elevation, AST elevation, ALKP elevation, GGT elevation, bilirubin elevation, bleeding events, gastrointestinal perforation"
295,OLYSIO,all-concat,"serious symptomatic bradycardia, hepatic decompensation, hepatic failure, photosensitivity, rash, pruritus, nausea, fatigue, headache, insomnia, dizziness, diarrhea, myalgia, dyspnea, hyperbilirubinemia, death"
296,ONGLYZA,all-concat,"upper respiratory tract infection, urinary tract infection, headache, peripheral edema, lymphopenia, rash, blood creatinine increased, blood creatine phosphokinase increased, sinusitis, abdominal pain, gastroenteritis, vomiting, fractures, thrombocytopenia, hypoglycemia, hypersensitivity reactions, urticaria, facial edema, tuberculosis, salmonella sepsis, death, anaphylaxis, angioedema, exfoliative skin conditions, acute pancreatitis, severe and disabling arthralgia"
297,OPDIVO,all-concat,"Immune-Mediated Pneumonitis, Immune-Mediated Colitis, Immune-Mediated Hepatitis, Immune-Mediated Nephritis and Renal Dysfunction, Immune-Mediated Hypothyroidism, Immune-Mediated Hyperthyroidism, Other Immune-Mediated Adverse Reactions, Rash, Fatigue, Dyspnea, Musculoskeletal Pain, Decreased Appetite, Cough, Nausea, Constipation, Abdominal Pain, Hyponatremia, Increased Aspartate Aminotransferase, Increased Lipase, Pruritus, Peripheral Edema, Ventricular Arrhythmia, Iridocyclitis, Infusion-Related Reactions, Increased Amylase, Dizziness, Peripheral and Sensory Neuropathy, Exfoliative Dermatitis, Erythema Multiforme, Vitiligo, Psoriasis, Increased Alkaline Phosphatase, Hyperkalemia, Increased ALT, Asthenia, Pyrexia, Chest Pain, Pain, Arthralgia, Vomiting, Diarrhea, Rash, Decreased Weight, Pneumonia, Stomatitis, Peripheral Neuropathy, Bronchitis, Upper Respiratory Tract Infection, Hyponatremia, Increased Creatinine, Hypercalcemia, Hypokalemia, Hypomagnesemia, Hypocalcemia, Hyperkalemia, Increased AST, Increased Alkaline Phosphatase, Increased ALT, Lymphopenia, Anemia, Thrombocytopenia, Adrenal Insufficiency, Uveitis, Pancreatitis, Facial and Abducens Nerve Paresis, Demyelination, Autoimmune Neuropathy, Motor Dysfunction, Vasculitis, Hypophysitis, Diabetic Ketoacidosis, Hypopituitarism, Guillain-Barre Syndrome, Myasthenic Syndrome, death"
298,OPSUMIT,all-concat,"Embryo-fetal toxicity, Hepatotoxicity, Decrease in hemoglobin, Anemia, Nasopharyngitis, Pharyngitis, Bronchitis, Headache, Influenza, Urinary tract infection, Hypersensitivity reactions, Angioedema, Pruritus, Rash, Nasal congestion, Pulmonary edema, Decreased sperm counts"
299,ORBACTIV,all-concat,"hypersensitivity reactions, infusion related reactions, Clostridium difficile-associated diarrhea, osteomyelitis, headache, nausea, vomiting, limb and subcutaneous abscesses, diarrhea, cellulitis, dizziness, infusion site phlebitis, infusion site reaction, abscess (limb and subcutaneous), alanine aminotransferase increased, aspartate aminotransferase increased, tachycardia, anemia, eosinophilia, infusion site erythema, extravasation, induration, pruritis, rash, edema peripheral, hypersensitivity, osteomyelitis, total bilirubin increased, hyperuricemia, hypoglycemia, tenosynovitis, myalgia, bronchospasm, wheezing, urticaria, angioedema, erythema multiforme, leucocytoclastic vasculitis, bleeding (associated with warfarin co-administration)"
300,OSPHENA,all-concat,"hot flush, vaginal discharge, muscle spasms, genital discharge, hyperhidrosis, thromboembolic stroke, hemorrhagic stroke, deep vein thrombosis (DVT), allergic conditions, hypersensitivity, angioedema, rash, rash erythematous, rash generalized, pruritus, urticaria, endometrial cancer, stroke, coronary heart disease, myocardial infarction (MI), venous thromboembolism, pulmonary embolism (PE), endometrial hyperplasia, uterine polyps"
301,PERJETA,all-concat,"Left Ventricular Dysfunction, Embryo-Fetal Toxicity, Infusion-Related Reactions, Hypersensitivity Reactions, Anaphylaxis, Diarrhea, Alopecia, Neutropenia, Nausea, Fatigue, Rash, Peripheral Neuropathy, Febrile Neutropenia, Leukopenia, Anemia, Asthenia, Edema Peripheral, Mucosal Inflammation, Pyrexia, Nail Disorder, Pruritus, Dry Skin, Vomiting, Constipation, Stomatitis, Headache, Dysgeusia, Dizziness, Myalgia, Arthralgia, Upper Respiratory Tract Infection, Nasopharyngitis, Dyspnea, Decreased Appetite, Lacrimation Increased, Insomnia, Paronychia, Pleural Effusion, Symptomatic Left Ventricular Systolic Dysfunction (CHF), Oligohydramnios, Delayed Renal Development, Death (if a fatal event is listed), Hypokalemia, ALT Increased, Thrombocytopenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Dyspepsia, Cough, Epistaxis, Oropharyngeal Pain, Symptomatic Left Ventricular Dysfunction (CHF)."
302,PLEGRIDY,all-concat,"Hepatic Injury, Hepatic Injury, Depression, Suicide, Seizures, Anaphylaxis, Allergic Reactions, Injection Site Reactions, Congestive Heart Failure, Decreased Peripheral Blood Counts, Autoimmune Disorders, Injection Site Erythema, Influenza-Like Illness, Pyrexia, Headache, Myalgia, Chills, Injection Site Pain, Asthenia, Injection Site Pruritus, Arthralgia, Nausea, Vomiting, Hyperthermia, Pain, Injection Site Edema, Injection Site Warmth, Injection Site Hematoma, Injection Site Rash, Body Temperature Increased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-Glutamyl-Transferase Increased, Pruritus, Flu-Like Symptoms, Hepatitis, Autoimmune Hepatitis, Severe Hepatic Failure, Asymptomatic Elevation of Hepatic Transaminases, Suicidal Ideation, Serious Allergic Reactions, Angioedema, Urticaria, Injection Site Necrosis, Cardiomyopathy, Pancytopenia, Severe Thrombocytopenia, Idiopathic Thrombocytopenia, Hyperthyroidism, Hypothyroidism, Autoimmune Hepatitis"
303,POMALYST,all-concat,"fetal risk, venous thromboembolism, arterial thromboembolism, hematologic toxicity, hepatotoxicity, hypersensitivity reactions, dizziness, confusional state, neuropathy, second primary malignancies, tumor lysis syndrome, fatigue, asthenia, neutropenia, anemia, constipation, nausea, diarrhea, dyspnea, upper respiratory tract infections, back pain, pyrexia, leukopenia, febrile neutropenia, lymphopenia, edema peripheral, chills, vomiting, musculoskeletal chest pain, muscle spasms, arthralgia, muscular weakness, bone pain, musculoskeletal pain, pain in extremity, pneumonia, urinary tract infection, sepsis, decreased appetite, hypercalcemia, hypokalemia, hyperglycemia, hyponatremia, dehydration, hypocalcemia, cough, epistaxis, productive cough, oropharyngeal pain, peripheral neuropathy, headache, tremor, rash, pruritus, dry skin, hyperhidrosis, night sweats, blood creatinine increased, weight decreased, weight increased, anxiety, insomnia, renal failure, myocardial infarction, atrial fibrillation, angina pectoris, cardiac failure congestive, vertigo, abdominal pain, general physical health deterioration, non-cardiac chest pain, multi-organ failure, hyperbilirubinemia, pneumocystis jiroveci pneumonia, respiratory syncytial virus infection, bacteremia, pneumonia respiratory syncytial viral, cellulitis, urosepsis, septic shock, clostridium difficile colitis, pneumonia streptococcal, lobar pneumonia, viral infection, lung infection, hemoglobin decreased, fall, compression fracture, spinal compression fracture, hyperkalemia, failure to thrive, depressed level of consciousness, syncope, mental status change, urinary retention, interstitial lung disease, pulmonary embolism, respiratory failure, bronchospasm, hypotension, pancytopenia, allergic reactions, angioedema, urticaria, elevated liver enzymes, hepatic failure, death."
304,PREPOPIK,all-concat,"nausea, headache, vomiting, electrolyte abnormalities, hypokalemia, hyponatremia, hypermagnesemia, abdominal pain, diarrhea, fecal incontinence, proctalgia, reversible aphthoid ileal ulcers, ischemic colitis, generalized tonic-clonic seizures, arrhythmia, renal impairment, mucosal ulcerations, aspiration"
305,RAPIVAB,all-concat,"diarrhea, serious skin reactions, hypersensitivity reactions, Stevens-Johnson Syndrome, erythema multiforme, neuropsychiatric events, hallucinations, delirium, abnormal behavior, death, Alanine Aminotransferase increased, Serum Glucose increased, Creatine Phosphokinase increased, Neutrophils decreased, constipation, insomnia, AST increased, hypertension, exfoliative dermatitis, rash"
306,RAXIBACUMAB,all-concat,"rash, pain in extremity, pruritus, somnolence, urticaria, clonus, dyspnea, anemia, leukopenia, lymphadenopathy, palpitations, vertigo, fatigue, infusion site pain, peripheral edema, blood amylase increased, blood creatine phosphokinase increased, prothrombin time prolonged, back pain, muscle spasms, syncope vasovagal, insomnia, flushing, hypertension"
307,RELISTOR,all-concat,"Gastrointestinal perforation, Severe or persistent diarrhea, Opioid withdrawal, Abdominal pain, Nausea, Diarrhea, Hyperhidrosis, Hot flush, Tremor, Chills, Flatulence, Dizziness, Vomiting, Feeling of body temperature change, Piloerection, Myocardial infarction (death), Stroke (death), Cardiac arrest (death), Sudden death, Cramping, Diaphoresis, Flushing, Malaise, Pain, Anxiety, Yawning"
308,SABRIL,all-concat,"Vision Loss, Magnetic Resonance Imaging (MRI) Abnormalities in Infants, Neurotoxicity, Suicidal Behavior and Ideation, Withdrawal of Antiepileptic Drugs (AEDs), Anemia, Somnolence and Fatigue, Peripheral Neuropathy, Weight Gain, Edema, Fatigue, Nystagmus, Tremor, Vision Blurred, Memory Impairment, Arthralgia, Abnormal Coordination, Confusional State, Upper Respiratory Tract Infection, Aggression, Diplopia, Bronchitis, Ear Infection, Otitis Media Acute, Headache, Dizziness, Convulsion, Nasopharyngitis, Visual Field Defect, Depression, Nausea, Diarrhea, Insomnia, Irritability, Vomiting, Influenza, Pyrexia, Rash, Tinnitus, Vertigo, Asthenopia, Eye Pain, Gastrointestinal Disorders, Abdominal Pain Upper, Dyspepsia, Stomach Discomfort, Abdominal Pain, Toothache, Abdominal Distension, Gait Disturbance, Asthenia, Oedema Peripheral, Fever, Chest Pain, Thirst, Malaise, Urinary Tract Infection, Contusion, Joint Sprain, Muscle Strain, Wound Secretion, Increased Appetite, Back Pain, Pain in Extremity, Myalgia, Muscle Twitching, Muscle Spasms, Disturbance in Attention, Sensory Disturbance, Hyporeflexia, Paraesthesia, Lethargy, Hyperreflexia, Hypoaesthesia, Sedation, Status Epilepticus, Dysarthria, Postictal State, Sensory Loss, Anxiety, Depressed Mood, Thinking Abnormal, Abnormal Behaviour, Expressive Language Disorder, Nervousness, Abnormal Dreams, Dysmenorrhoea, Erectile Dysfunction, Pharyngolaryngeal Pain, Cough, Pulmonary Congestion, Sinus Headache, Acne, Psychomotor Hyperactivity, Disorientation, Strabismus, Conjunctivitis, Vomiting, Constipation, Diarrhea, Fever, Viral Infection, Pneumonia, Candidiasis, Ear Infection, Gastroenteritis Viral, Sinusitis, Urinary Tract Infection, Croup Infectious, Decreased Appetite, Sedation, Somnolence, Status Epilepticus, Lethargy, Convulsion, Hypotonia, Irritability, Insomnia, Nasal Congestion, Rash, Congenital Cardiac Defects, Congenital External Ear Anomaly, Congenital Hemangioma, Congenital Hydronephrosis, Congenital Male Genital Malformation, Congenital Oral Malformation, Congenital Vesicoureteric Reflux, Dentofacial Anomaly, Dysmorphism, Fetal Anticonvulsant Syndrome, Hamartomas, Hip Dysplasia, Limb Malformation, Limb Reduction Defect, Low Set Ears, Renal Aplasia, Retinitis Pigmentosa, Supernumerary Nipple, Talipes, Deafness, Delayed Puberty, Gastrointestinal Hemorrhage, Esophagitis, Developmental Delay, Facial Edema, Malignant Hyperthermia, Multi-Organ Failure, Cholestasis, Dystonia, Encephalopathy, Hypertonia, Muscle Spasticity, Myoclonus, Optic Neuritis, Dyskinesia, Acute Psychosis, Apathy, Delirium, Hypomania, Neonatal Agitation, Psychotic Disorder, Laryngeal Edema, Pulmonary Embolism, Respiratory Failure, Stridor, Angioedema, Maculo-Papular Rash, Pruritus, Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), death (if a fatal event is listed)."
309,SAMSCA,all-concat,"thirst, dry mouth, asthenia, constipation, pollakiuria, polyuria, hyperglycemia, nausea, mortality, gastrointestinal bleeding, disseminated intravascular coagulation, intracardiac thrombus, ventricular fibrillation, prothrombin time prolonged, ischemic colitis, diabetic ketoacidosis, rhabdomyolysis, cerebrovascular accident, urethral hemorrhage, vaginal hemorrhage, pulmonary embolism, respiratory failure, deep vein thrombosis, osmotic demyelination syndrome, hypernatremia, hypersensitivity reactions, anaphylactic shock, rash generalized, dehydration, hypovolemia, liver injury, death"
310,SAVELLA,all-concat,"nausea, headache, constipation, dizziness, insomnia, hot flush, hyperhidrosis, vomiting, palpitations, heart rate increased, dry mouth, hypertension, tachycardia, vision blurred, abdominal pain, chest pain, chills, chest discomfort, dysuria, ejaculation disorder, erectile dysfunction, ejaculation failure, libido decreased, prostatitis, scrotal pain, testicular pain, testicular swelling, urinary hesitation, urinary retention, urethral pain, urine flow decreased, diarrhea, dyspepsia, gastroesophageal reflux disease, flatulence, abdominal distension, fatigue, peripheral edema, irritability, pyrexia, urinary tract infection, cystitis, contusion, fall, weight decreased, weight increased, hypercholesterolemia, somnolence, dysgeusia, depression, stress, night sweats, leukopenia, neutropenia, thrombocytopenia, supraventricular tachycardia, accommodation disorder, hyperprolactinemia, hepatitis, anorexia, hyponatremia, rhabdomyolysis, convulsions, loss of consciousness, Parkinsonism, aggression, anger, delirium, hallucination, homicidal ideation, acute renal failure, galactorrhea, erythema multiforme, Stevens Johnson syndrome, hypertensive crisis, suicidality, serotonin syndrome, seizures, hepatotoxicity, withdrawal symptoms, abnormal bleeding, mania, dysuria, angle closure glaucoma, death"
311,SIGNIFOR,all-concat,"hypocortisolism, hyperglycemia, diabetes mellitus, bradycardia, QT prolongation, liver test elevations, cholelithiasis, pituitary hormone deficiency, diarrhea, nausea, headache, abdominal pain, fatigue, injection site reactions, nasopharyngitis, alopecia, asthenia, glycosylated hemoglobin increased, alanine aminotransferase increased, gamma-glutamyl transferase increased, edema peripheral, abdominal pain upper, decreased appetite, hypercholesterolemia, hypertension, dizziness, hypoglycemia, type 2 diabetes mellitus, anxiety, influenza, insomnia, myalgia, arthralgia, pruritus, lipase increased, constipation, hypotension, vomiting, back pain, dry skin, electrocardiogram QT prolonged, hypokalemia, pain in extremity, sinus bradycardia, vertigo, abdominal distension, adrenal insufficiency, aspartate aminotransferase increased, blood glucose increased, anemia, blood amylase increased, prothrombin time prolonged, gastrointestinal disorders, elevated liver tests, thyroid function abnormalities, other abnormal laboratory findings, hypocortisolism, hyperglycemia and diabetes, bradycardia and QT prolongation, liver test elevations, cholelithiasis, deficiency of pituitary hormones"
312,SIVEXTRO,all-concat,"nausea, headache, diarrhea, vomiting, dizziness, anemia, palpitations, tachycardia, asthenopia, vision blurred, visual impairment, vitreous floaters, infusion-related reactions, drug hypersensitivity, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, white blood cell count decreased, hypoesthesia, paresthesia, VIIth nerve paralysis, insomnia, pruritus, urticaria, dermatitis, flushing, hypertension, myelosuppression, peripheral neuropathy, optic neuropathy"
313,SOVALDI,all-concat,"Serious Symptomatic Bradycardia, fatigue, headache, nausea, insomnia, anemia, pancytopenia, severe depression, suicidal ideation, suicide, death"
314,STELARA,all-concat,"Infections, Malignancies, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), Nasopharyngitis, Upper respiratory tract infection, Headache, Fatigue, Diarrhea, Back pain, Dizziness, Pharyngolaryngeal pain, Pruritus, Injection site erythema, Myalgia, Depression, Cellulitis, Herpes zoster, Diverticulitis, Injection site reactions (pain, swelling, pruritus, induration, hemorrhage, bruising, irritation), Serious hypersensitivity reactions (including anaphylaxis and angioedema), Other hypersensitivity reactions (including rash and urticaria), Pustular psoriasis, Erythrodermic psoriasis, Arthralgia, Nausea, Dental infections, Serious bacterial infections, Fungal infections, Viral infections, Diverticulitis, Cellulitis, Pneumonia, Appendicitis, Cholecystitis, Sepsis, Osteomyelitis, Gastroenteritis, Urinary tract infections, Tuberculosis (TB), Non-melanoma skin cancer, Prostate cancer, Melanoma, Colorectal cancer, Breast cancer, Death (associated with RPLS and fatal outcomes reported in the context of particular infections and malignancies)."
315,STIVARGA,all-concat,"hepatotoxicity, hemorrhage, death, dermatological toxicity, hypertension, cardiac ischemia and infarction, reversible posterior leukoencephalopathy syndrome (RPLS), gastrointestinal perforation or fistula, wound healing complications, embryofetal toxicity, hypersensitivity reaction, asthenia/fatigue, hand-foot skin reaction (HFSR), diarrhea, decreased appetite/food intake, mucositis, dysphonia, infection, pain (not otherwise specified), decreased weight, gastrointestinal and abdominal pain, rash, fever, nausea, anemia, thrombocytopenia, neutropenia, lymphopenia, hypocalcemia, hypokalemia, hyponatremia, hypophosphatemia, hyperbilirubinemia, increased AST, increased ALT, proteinuria, increased INR, increased lipase, increased amylase, alopecia, headache, musculoskeletal stiffness, hypothyroidism"
316,STRIVERDI,all-concat,"asthma-related death, nasopharyngitis, upper respiratory tract infection, bronchitis, urinary tract infection, cough, dizziness, rash, diarrhea, back pain, arthralgia, pneumonia, constipation, pyrexia, worsening COPD, COPD exacerbation, atrial fibrillation, lung cancer, paradoxical bronchospasm, cardiovascular effects, ECG changes, hypokalemia, hyperglycemia, angioedema"
317,SURFAXIN,all-concat,"endotracheal tube reflux, pallor, endotracheal tube obstruction, need for dose interruption, oxygen desaturation, bradycardia, anemia, jaundice, metabolic acidosis, hyperglycemia, pneumonia, hyponatremia, hypotension, respiratory acidosis, death, multi-organ failure, sepsis, anoxic encephalopathy, renal failure, pneumothorax, pulmonary embolism"
318,SYLVANT,all-concat,"severe infections, infusion-related reactions, hypersensitivity, pruritus, increased weight, rash, hyperuricemia, upper respiratory tract infection, rash (rash, rash generalized, rash maculo-papular, rash popular, rash pruritic), skin hyperpigmentation, eczema, psoriasis, dry skin, lower respiratory tract infection, thrombocytopenia, edema (general and localized), constipation, hypertriglyceridemia, hypercholesterolemia, oropharyngeal pain, renal impairment, headache, weight increased, hypotension, abdominal pain/abdominal distension, decreased appetite, dehydration, peripheral edema, diarrhea, pain in extremities, arthralgia, fatigue, anaphylaxis, back pain, chest pain or discomfort, nausea and vomiting, flushing, erythema, palpitations, gastrointestinal perforation"
319,SYNRIBO,all-concat,"thrombocytopenia, anemia, neutropenia, diarrhea, nausea, fatigue, asthenia, injection site reaction, pyrexia, infection, lymphopenia, pancytopenia, increased alanine aminotransferase, bone marrow failure, febrile neutropenia, constipation, abdominal pain, upper abdominal pain, vomiting, edema peripheral, anorexia, arthralgia, pain in extremity, back pain, myalgia, headache, insomnia, cough, epistaxis, alopecia, rash, leukocytosis, chills, dyspnea, hyperosmolar non-ketotic hyperglycemia, elevated transaminases, hemoglobin decreased, leukocytes decreased, neutrophils decreased, platelets decreased, alanine aminotransferase increased, bilirubin increased, creatinine increased, glucose increased, uric acid increased, glucose decreased, tachycardia, palpitations, acute coronary syndrome, angina pectoris, arrhythmia, bradycardia, ventricular extrasystoles, ear pain, ear hemorrhage, tinnitus, cataract, vision blurred, conjunctival hemorrhage, dry eye, lacrimation increased, conjunctivitis, diplopia, eye pain, eyelid edema, stomatitis, mouth ulceration, abdominal distension, dyspepsia, gastroesophageal reflux disease, gingival bleeding, aphthous stomatitis, dry mouth, hemorrhoids, gastritis, gastrointestinal hemorrhage, melena, mouth hemorrhage, oral pain, anal fissure, dysphagia, gingival pain, gingivitis, mucosal inflammation, pain, chest pain, hyperthermia, influenza-like illness, catheter site pain, general edema, malaise, hypersensitivity, contusion, transfusion reaction, decreased appetite, diabetes mellitus, gout, dehydration, bone pain, muscular weakness, muscle spasms, musculoskeletal chest pain, musculoskeletal pain, musculoskeletal stiffness, musculoskeletal discomfort, dizziness, cerebral hemorrhage, paresthesia, convulsion, hypoesthesia, lethargy, sciatica, burning sensation, dysgeusia, tremor, anxiety, depression, agitation, confusional state, mental status change, dysuria, pharyngolaryngeal pain, nasal congestion, dysphonia, productive cough, rales, rhinorrhea, hemoptysis, sinus congestion, erythema, pruritus, dry skin, petechiae, hyperhidrosis, night sweats, ecchymosis, purpura, skin lesion, skin ulcer, rash erythematous, rash papular, skin exfoliation, skin hyperpigmentation, hematoma, hypertension, hot flush, hypotension, death."
320,TRADJENTA,all-concat,"nasopharyngitis, hypoglycemia, diarrhea, cough, urinary tract infection, hypertriglyceridemia, hyperlipidemia, weight increased, constipation, back pain, arthralgia, upper respiratory tract infection, headache, pain in extremity, hypersensitivity, urticaria, angioedema, localized skin exfoliation, bronchial hyperreactivity, myalgia, pancreatitis, death, severe hypoglycemia, acute pancreatitis, anaphylaxis, exfoliative skin conditions, severe and disabling arthralgia, rash, mouth ulceration, stomatitis"
321,VIBATIV,all-concat,"Nephrotoxicity, Infusion-related reactions, Clostridium difficile-associated diarrhea, Diarrhea, Taste disturbance, Nausea, Vomiting, Foamy urine, Death, Renal events, Renal impairment, Renal insufficiency, Renal failure, Acute renal failure, Electrocardiogram QTc interval prolonged, Serious hypersensitivity reactions, Anaphylactic reactions, Decreased appetite, Rigors, Increased serum creatinine, Hypersensitivity reactions, QTc prolongation"
322,VICTOZA,all-concat,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Renal Impairment, Hypersensitivity Reactions, headache, nausea, diarrhea, anti-liraglutide antibody formation, Immunogenicity-related events, urticaria, gastrointestinal adverse reactions, vomiting, dyspepsia, constipation, infections, upper respiratory tract infections, Injection site reactions, injection site rash, erythema, Papillary thyroid carcinoma, Dehydration, Increased serum creatinine, acute renal failure, worsening of chronic renal failure, Angioedema, anaphylactic reactions, Allergic reactions, rash, pruritus, Acute pancreatitis, hemorrhagic pancreatitis, necrotizing pancreatitis, death"
323,VIEKIRA,all-concat,"Increased Risk of ALT Elevations, fatigue, nausea, pruritus, other skin reactions, insomnia, asthenia, serious adverse event (SAE), skin reactions, rash, erythema, eczema, rash maculo-papular, rash macular, dermatitis, rash papular, skin exfoliation, rash pruritic, rash erythematous, rash generalized, dermatitis allergic, dermatitis contact, exfoliative rash, photosensitivity reaction, psoriasis, skin reaction, ulcer, urticaria, dyspnea, Serum ALT Elevations, Serum Bilirubin Elevations, Anemia/Decreased Hemoglobin, headache, cough, irritability, ocular icterus, hyperbilirubinemia, diarrhea, muscle spasms, Hypersensitivity reactions, angioedema"
324,VIIBRYD,all-concat,"Suicidal Thoughts and Behaviors, Serotonin Syndrome, Increased Risk of Bleeding, Activation of Mania or Hypomania, Discontinuation Syndrome, Seizures, Angle-Closure Glaucoma, Hyponatremia, diarrhea, nausea, vomiting, insomnia, abdominal pain, dyspepsia, flatulence, gastroenteritis, abdominal distension, headache, dizziness, somnolence, paresthesia, abnormal dreams, restlessness, fatigue, palpitations, increased appetite, arthralgia, increased weight, abnormal orgasm, anorgasmia, erectile dysfunction, libido decreased, ejaculation disorder, ventricular extrasystoles, dry eye, vision blurred, cataracts, sedation, tremor, migraine, panic attack, hyperhidrosis, night sweats, irritability, hallucinations, suicide attempt, suicidal ideation, rash, generalized rash, urticaria, drug eruption, death"
325,VIMPAT,all-concat,"Suicidal Behavior and Ideation, Dizziness, Ataxia, Cardiac Rhythm and Conduction Abnormalities, Syncope, Multiorgan Hypersensitivity Reactions, Insomnia, Headache, Nausea, Somnolence, Fatigue, Diplopia, Vomiting, Vertigo, Blurred Vision, Diarrhea, Gait Disturbance, Asthenia, Contusion, Skin Laceration, Tremor, Nystagmus, Balance Disorder, Memory Impairment, Depression, Pruritus, Neutropenia, Anemia, Palpitations, Tinnitus, Constipation, Dyspepsia, Dry Mouth, Oral Hypoaesthesia, Irritability, Pyrexia, Feeling Drunk, Fall, Muscle Spasms, Paresthesia, Cognitive Disorder, Hypoaesthesia, Dysarthria, Disturbance in Attention, Cerebellar Syndrome, Confusional State, Mood Altered, Depressed Mood, Injection Site Pain or Discomfort, Injection Site Irritation, Injection Site Erythema, Profound Bradycardia, Chest Pain, Abnormal Coordination, Hyperhidrosis, Agranulocytosis, Aggression, Agitation, Hallucination, Psychotic Disorder, Angioedema, Rash, Urticaria, Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, Hepatitis, Nephritis, Eosinophilia, Lymphadenopathy, Myocarditis"
326,VOTRIENT,all-concat,"diarrhea, hypertension, hair color changes (depigmentation), nausea, anorexia, vomiting, fatigue, decreased weight, decreased appetite, tumor pain, dysgeusia, headache, musculoskeletal pain, myalgia, gastrointestinal pain, dyspnea, hepatotoxicity, QT prolongation, torsades de pointes, cardiac dysfunction, hemorrhagic events, arterial thromboembolic events, venous thromboembolic events, thrombotic microangiopathy, gastrointestinal perforation, fistula, interstitial lung disease (ILD)/pneumonitis, reversible posterior leukoencephalopathy syndrome (RPLS), infection, increased toxicity with other cancer therapies, renal cell carcinoma, soft tissue sarcoma, asthenia, abdominal pain, alopecia, chest pain, dysgeusia (altered taste), dyspepsia, dysphonia, facial edema, palmar-plantar erythrodysesthesia (hand-foot syndrome), proteinuria, rash, skin depigmentation, weight decreased, arthralgia, muscle spasms, leukopenia, neutropenia, thrombocytopenia, lymphocytopenia, ALT increased, AST increased, glucose increased, total bilirubin increased, phosphorus decreased, sodium decreased, magnesium decreased, glucose decreased, exfoliative rash, cough, peripheral edema, mucositis, dizziness, skin disorder, skin hypopigmentation, stomatitis, insomnia, hypothyroidism, epistaxis, left ventricular dysfunction, dry skin, chills, vision blurred, nail disorder, lipase elevations, pancreatitis, pneumothorax, bradycardia, retinal detachment/tear, severe and fatal hepatotoxicity, death."
327,VPRIV,all-concat,"hypersensitivity reactions, headache, dizziness, abdominal pain, nausea, back pain, joint pain, prolonged activated PTT, fatigue, asthenia, pyrexia, bone pain, tachycardia, rash, urticaria, flushing, hypertension, hypotension, anaphylaxis, chest discomfort, dyspnea, pruritus, body temperature increased"
328,XARELTO,all-concat,"Increased risk of stroke, Bleeding risk, Spinal/epidural hematoma, Major bleeding, Bleeding into a critical organ, Fatal bleeding, Gastrointestinal bleeding, Non-fatal critical organ bleeding, Non-fatal non-critical organ bleeding, Clinically relevant non-major bleeding, Any bleeding, Menorrhagia, Pulmonary hemorrhage, Pulmonary hemorrhage with bronchiectasis, Agranulocytosis, Thrombocytopenia, Retroperitoneal hemorrhage, Jaundice, Cholestasis, Hepatitis, Hepatocellular injury, Hypersensitivity, Anaphylactic reaction, Anaphylactic shock, Angioedema, Cerebral hemorrhage, Subdural hematoma, Epidural hematoma, Hemiparesis, Stevens-Johnson syndrome, Pregnancy-related hemorrhage, death"
329,XELJANZ,all-concat,"upper respiratory tract infections, headache, diarrhea, nasopharyngitis, serious infections, pneumonia, cellulitis, herpes zoster, urinary tract infection, tuberculosis, opportunistic infections, malignancies, lymphoma, lung cancer, breast cancer, gastric cancer, colorectal cancer, renal cell cancer, prostate cancer, malignant melanoma, lymphopenia, neutropenia, liver enzyme elevations, drug-induced liver injury, lipid elevations, serum creatinine elevations, anemia, diverticulitis, dehydration, insomnia, paresthesia, dyspnea, cough, sinus congestion, abdominal pain, dyspepsia, vomiting, gastritis, nausea, hepatic steatosis, rash, erythema, pruritus, musculoskeletal pain, arthralgia, tendonitis, joint swelling, non-melanoma skin cancers, pyrexia, fatigue, peripheral edema, gastrointestinal perforations, Epstein Barr Virus-associated post-transplant lymphoproliferative disorder"
330,XENAZINE,all-concat,"Depression, suicidality, akathisia, restlessness, agitation, parkinsonism, dysphagia, sedation, somnolence, fatigue, insomnia, anxiety, nausea, irritability, decreased appetite, obsessive reaction, balance difficulty, bradykinesia, dizziness, dysarthria, unsteady gait, headache, vomiting, fall, laceration (head), ecchymosis, upper respiratory tract infection, shortness of breath, bronchitis, dysuria, tremor, confusion, worsening aggression, pneumonia, hyperhidrosis, skin rash, neuroleptic malignant syndrome (NMS), QTc prolongation, hypotension, orthostatic hypotension, hyperprolactinemia, tardive dyskinesia (TD), death"
331,XOFIGO,all-concat,"Bone Marrow Suppression, nausea, diarrhea, vomiting, peripheral edema, anemia, lymphocytopenia, leukopenia, thrombocytopenia, neutropenia, pancytopenia, renal failure and impairment, dehydration, erythema, pain, edema at the injection site, secondary malignant neoplasms, osteosarcoma, bone marrow failure, vascular hemorrhage, myelosuppression, serious infections, febrile neutropenia, death"
332,ZALTRAP,all-concat,"Hemorrhage, Gastrointestinal Perforation, Compromised Wound Healing, Fistula Formation, Hypertension, Arterial Thromboembolic Events, Proteinuria, Neutropenia, Neutropenic Complications, Diarrhea, Dehydration, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), Leukopenia, AST increased, Stomatitis, Fatigue, Thrombocytopenia, ALT increased, Weight decreased, Decreased Appetite, Epistaxis, Abdominal Pain, Dysphonia, Serum Creatinine increased, Headache, Urinary Tract Infection, Hematuria, Post-procedural Hemorrhage, Intracranial Hemorrhage, Pulmonary Hemorrhage/Hemoptysis, Severe Hypersensitivity Reactions, Venous Thromboembolic Events, Deep Venous Thrombosis, Pulmonary Embolism, Severe Proteinuria, Nephrotic Syndrome, Thrombotic Microangiopathy (TMA), Febrile Neutropenia, Neutropenic Infection/Sepsis, Severe Diarrhea, Severe Dehydration, Palmar-Plantar Erythrodysesthesia Syndrome, Skin Hyperpigmentation, Dyspnea, Oropharyngeal Pain, Rhinorrhea, Hemorrhoids, Rectal Hemorrhage, Proctalgia, Abdominal Pain Upper, death"
333,ZELBORAF,all-concat,"new primary malignancies, hypersensitivity reactions, dermatologic reactions, QT prolongation, hepatotoxicity, photosensitivity, ophthalmologic reactions, radiation sensitization, radiation recall, arthralgia, rash, alopecia, fatigue, photosensitivity reaction, nausea, pruritus, skin papilloma, cuSCC, rash maculo-papular, actinic keratosis, dry skin, rash papular, erythema, myalgia, pain in extremity, musculoskeletal pain, back pain, fatigue, edema peripheral, pyrexia, asthenia, nausea, diarrhea, vomiting, constipation, headache, dysgeusia, skin papilloma, cutaneous SCC, seborrheic keratosis, gamma-glutamyltransferase increased, decreased appetite, cough, sunburn, palmar-plantar erythrodysesthesia syndrome, keratosis pilaris, panniculitis, erythema nodosum, Stevens-Johnson syndrome, toxic epidermal necrolysis, arthritis, neuropathy peripheral, VIIth nerve paralysis, basal cell carcinoma, oropharyngeal squamous cell carcinoma, folliculitis, retinal vein occlusion, vasculitis, atrial fibrillation, progression of pre-existing chronic myelomonocytic leukemia with NRAS mutation, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), neutropenia, pancreatitis, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, non-cutaneous squamous cell carcinoma, tumor promotion in BRAF wild-type melanoma, serious hypersensitivity reactions including anaphylaxis and DRESS syndrome, severe dermatologic reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis, concentration-dependent QT prolongation, liver injury leading to functional hepatic impairment, mild to severe photosensitivity, uveitis, blurry vision, photophobia, embryo-fetal toxicity, radiation sensitization and recall involving cutaneous and visceral organs."
334,ZIOPTAN,all-concat,"conjunctival hyperemia, ocular stinging/irritation, ocular pruritus, allergic conjunctivitis, cataract, dry eye, ocular pain, eyelash darkening, growth of eyelashes, vision blurred, headache, common cold, cough, urinary tract infection, exacerbation of asthma, dyspnea, iritis/uveitis, deepening of the eyelid sulcus, increased pigmentation of the iris, increased pigmentation of the periorbital tissue, increased pigmentation of the eyelashes, iris color change, intraocular inflammation, macular edema"
335,ZONTIVITY,all-concat,"Bleeding, life-threatening bleeding, fatal bleeding, death, GUSTO severe bleeding, GUSTO moderate bleeding, GUSTO moderate or severe bleeding, Any GUSTO Bleeding (Severe/Moderate/Mild), Fatal Bleeding, Intracranial Hemorrhage (ICH), Clinically Significant Bleeding, Gastrointestinal Bleeding, Anemia, Depression, Rashes, Eruptions, Exanthemas, iron deficiency, retinopathy or retinal disorder, diplopia/oculomotor disturbances"
